Bio Job Blog : Bio Jobs : Biotechnology Jobs : Biopharmaceutical Jobs : Bioscience, Biotech Jobs : Bio Job Blog : Biocareer : Bio-Business Training, Biotechnology Training : Jobs in Biology : Internships in Biology : Internships in Biotechnology

Until recently, there was little or no mention of business activity within the emerging Chinese life sciences industry. However, as the Chinese middle class continues to grow, the need and demand for pharmaceutical and biotechnology drugs (including vaccines and other biologics continues) to grow at a frenetic pace. Further, a growing abundance of US-trained scientists has allowed the Chinese life science industry to develop much more quickly than anticipated. Also, many major pharmaceutical companies like Merck, Roche and Novartis have invested hundreds of millions of dollars in China and have already established world class Chinese R&D facilities. Finally, unlike in most Western countries, the Chinese government controls roughly 80% of the pharmaceutical and biologics manufacturing that takes place in China. Together, this suggests that China has quietly established itself as a life sciences power to be reckoned with! To that end, there were two reports that came across the transom this morning that piqued my interest. 

The first report was about a company called Lotus Pharmaceuticals, Inc.

"Lotus Pharmaceuticals, Inc., a growing developer and producer of prescription drugs and licensed national seller of pharmaceutical products in the People's Republic of China ("PRC"), reported the groundbreaking ceremony on March 9 to construct a new building complex on the grounds of its production facility in Beijing.

Officials of Beijing municipal and Chaoyang district governments, officers of the China State Food & Drug, and representatives of both state-owned and private pharmaceutical companies attended the ceremony. CEO, Zhongyi Liu, welcomed the guests. "After a year of planning, we are pleased to start the construction of the new building complex and expect to finish the construction by July, interior decoration by September and GMP certification by December of this year," he said. "This is a new page for Lotus' development and it will provide important impetus to profitable growth, which is anticipated to reach $150 million in annual sales during the first year after the facility, is fully operational."

The second reported on plans to build a venture-back, “private” contract manufacturing facility that specializes in biomanufacturing in metropolitan Beijing.

"AutekBio, Inc., SUMA Ventures and Beijing E-Town Harvest International Capital Management Corporation, a venture capital group from Beijing Municipal Government announced a joint investment of more than US$100m to develop a new contract manufacturing organization (CMO) for biopharmaceutical industry in China. This joint effort led by AutekBio represents strong interests from both private investment sector and government to establish world quality capability and capacity in biopharmaceutical manufacturing in China.

The new joint venture will build up a world class R&D and manufacturing center in southern Beijing to service international biologic developments, with combined volumes of bioreactors up to 20,000 liters in multiple production lines (trains). The firm will also benefit from financial, regulatory and other supports from the Chinese government for the biotech industry." 

It is becoming increasingly apparent that China has clearly set its sights on establishing itself as player on the global life sciences stage. After spending a week in China during the country’s preparation for the Beijing Games, I discovered that China can achieve any goal that it sets for itself in very short order.  

Until next time...  

Good Luck and Good Job Hunting (try China)!!!!!! 

• Email This
• Print
• Comments (1)
• Trackbacks
• Share Link

Abbott Laboratories yesterday announced that it will buy Facet Biotech Corp. for about $450 million in cash. Facet, along with its development partner Biogen Idec, had planned on moving a potential monoclonal antibody (MAb) treatment for multiple sclerosis called daclizumab into late stage clinical development in the second quarter of this year. The company is also developing several different cancer treatments with other pharmaceutical partners.

Abbott’s purchase of Facet signals Abbott Laboratories’ ongoing commitment to biotechnology or protein-based drugs. The company launched Humira (a fully human MAb treatment for rheumatoid arthritis and other inflammatory diseases) several years ago and it has managed to glean market share from older competitor’s products including Remicade (Johnson & Johnson) and Enbrel (Amgen/Pfizer) to become a blockbuster drug. MAbs are viewed by many as the “drugs of the future.” At present, there are over 350 MAb-based products in various stages of discovery and clinical development.

Earlier in the year, Biogen Idec offered to purchase Facet for $17.50 per share. Company executives and shareholders rejected the offer citing that they thought it was too low. Abbott offered $27 per share which represented a 67 percent premium to Facet’s closing stock price of $16.21 on Tuesday.  Both companies’ boards of directors have already approved the deal which is expected to close some time in the second quarter. It is not clear how the purchase will affect Facet employees but expect to see layoffs and a mass exodus by company executives.

Look for more cash purchases of biotech firms by pharmaceutical companies as debt continues to accrue and venture money remains scarce and difficult to come by.

Until next time...

Good Luck and Good Job Hunting!!!

• Email This
• Print
• Comments
• Trackbacks
• Share Link

Merck of Germany announced on Sunday that it had agreed to purchase Millipore, an American supplier of laboratory products and reagents for biotechnology companies for $7.2 billion. The offer comes in the wake of the $6.0 billion offer made last week by Thermo Fisher Scientific one of the largest supplier in the world of laboratory reagents, supplies and equipment. While somewhat of an unconventional move for a healthcare company, Merck executives hailed the acquisition as a strategic move for customers, stakeholders and share holders of both companies.

In other news, Astellas Pharmaceuticals, Japan’s second largest pharmaceutical company said today that it tendered an offer to acquire all outstanding shares of Long Island, NY-based OSI Pharmaceuticals for $52.00 per share or approximately $3.5 billion in cash. OSI, which manufactures and sells Tarceva (erlontinib) a treatment for non-small cell lung and pancreatic cancer (which it co-markets by Genentech in the US and globally with Roche), has a strong oncology pipeline and is also developing treatments for diabetes and obesity. Despite early success with Tarceva, cash-starved OSI has been struggling of late. The acquisition of OSI provides Astellas with a strong pipeline and entrée into the growing US oncology market. OSI would also complement Astellas’ existing strength and franchises in urology and immunology.

While mergers and acquisitions were largely anticipated in the US biopharmaceutical sector over the past few years, the acquisition of American companies like Millipore and OSI Pharmaceuticals by foreign companies suggests that there may be chinks in the armor of once dominant US biotechnology companies. The economic crisis coupled with America’s waning innovation in the life sciences sector suggests that other US-based biopharmaceutical companies may be at risk. Although most foreign governments stumbled when attempting to develop the own internal biotechnology expertise, many cash-rich foreign companies recognize that purchasing US companies with marketed products offers them an opportunity to quickly and strategically gain a foothold in the ever-expanding biotechnology market.

Until next time....

Good Luck and Good Buying!!!!!!!!!

• Email This
• Print
• Comments
• Trackbacks
• Share Link

While I don’t advocate postdoctoral positions for individuals unless they plan on doing bench science for the rest of their lives, postdoctoral training is a fact of life for those interested in pursuing academic careers. To that end, The Scientist.com conducts an annual survey that ranks the best 40 places for postdoctoral associates to work. The survey ranks the strengths and weaknesses of individual training institutions based on funding, facilities and infrastructure, benefits, training and mentoring and family and personal life. Surprisingly, institutions are also ranked on networking, career development and mentoring and training and mentor and training that they offer to their postdoctoral trainees.

The institution that snagged the top spot on the 2010 list was the Trudeau Institute in Saranac Lake, NY. Nestled in the Adirondack Mountains in Upstate NY, the not-for-profit Trudeau Institute has a deserved international reputation in immunology, infectious diseases and vaccinology. When I was a graduate students (back in the dark ages), some of the greatest minds in infectious diseases held positions at Trudeau. These days; not so much—but I bet the skiing is great! Interestingly, one of Trudeau’s strengths is networking opportunities (how much networking can take place at a secluded institute on a lake in the Adirondacks). Curiously, however, one of its major weaknesses is the lack of career development opportunities. Based on my life experiences, I always thought that networking was a crucial part of career development. But then again, what do I know?

The top 10 of the list featured a couple of Massachusetts-based institutions including the Whitehead Institute for Biomedical Research (3) and the Novartis Institute for Biomedical Research Institute in Cambridge (4) and Woods Hole Oceanographic Institute in Woods Hole, MA (9). Two national laboratories, Sandia National Laboratories, Livermore, CA (8) and Rocky Mountain Laboratory, NIH Hamilton, MT (6) cracked the top ten. By all accounts, the fly fishing is outstanding in Hamilton.

As usual, there were some surprises. These included Samuel Robert Noble Foundation (2) in Ardmore, OK, the University of Colorado, Denver (7) and the Mayo Clinic (10) in Rochester, MN (not exactly cities on my top ten list). Not surprisingly, there were only two life sciences companies that made the Top 40 list; Genentech (5) in South San Francisco and as mentioned above at number 3, the Novartis Institute for Biomedical Research. Once a mainstay, industrial postdocs are becoming increasingly scare and difficult to land. In many cases, these positions are not advertised and generally filled by word-of-mouth recommendations to principal investigators who are looking for postdoctoral fellows.

A quick perusal of the list revealed, as expected, that most of the 40 institutions excelled in categories that included funding, facilities and infrastructure, benefits and family and personal life. In marked contrast, many of the institutions on the list were disappointingly weak in the areas of networking, career development and training and mentoring. Of the top 40, six got kudos for networking (15%), 11 for career development (28%) and only 6 for training and mentoring (15%). These abysmal statistics are somewhat shocking given that postdoctoral fellowships are mainly intended to train and prepare aspiring individuals for lifelong careers as scientists. The fact that only 25% of the nation’s best places to perform postdoctoral research offer career development training and support for postdoctoral trainees suggests that the future of the American life sciences industry may be in serious jeopardy!

Hat tip Ed at Pharmalot.

Until next time....

Good Luck and Good Job Hunting!!!!!!!

• Email This
• Print
• Comments
• Trackbacks
• Share Link

American competitiveness in engineering, technology and science. Unfortunately, while American competitiveness and innovation in these areas continues to wane, little has been done (except talking) about it! Yesterday, Intel and 24 venture capital funds announced that they plan to invest $3.5 billion in American startups and early stage ventures over the next two years. Further, in addition, several of America’s leading technology companies including Google, Cisco Systems, Intel Microsoft and 13 others pledged to add as many as 10,500 jobs into 2010—mainly by hiring Americans graduating from colleges with degrees in computer science and engineering.

The initiative, named the Invest in America Alliance was formed in response to “steadily declining long-term investments in education, technology and human capital” that has been taking place in the US for past 20 years or more. Put simply, the American education system is not training enough qualified individuals to allow the US to compete with other emerging technology and engineering powerhouses that include China, India Finland, Korea and the Netherlands. 

According to Robert Compton, a venture capitalist, entrepreneur and education enthusiast “Fewer than 10 percent of college graduates in the US have engineering degrees, compared with more than one-third in India and China and more foreign-born graduates of US universities are returning to their home countries.” For those of you with degrees in math and science (and you base your calculations on population size), the magnitude of the problem (for Americans anyway) is glaringly obvious. Compton went on to say what many others have been thinking for a while, “Early indicators are that we are not the center of innovation anymore. It is shifting to the East.” And he may be right! Based on surveys conducted by the World Intellectual Property Organization in the last year, patent filings increased 30 percent in China while declining 11 percent in the US.

While the Invest in America Alliance appears to be a great public relations opportunity for the companies and venture firms that are participating in it, its critics doubt whether investing more money in technology startups is going to fix the ongoing problem. Education analysts contend that a better and cheaper solution may be changing US immigration laws so that foreign students who train in the US are allowed to remain in the country after they complete their training. Other naysayers contend that most of the venture money committed by the alliance would have likely gone to American startups anyway (US based venture firms already invest 70 percent of their money in American start ups) and that 10,500 new jobs isn’t enough to make a dent in the US unemployment rolls.

Like the technology industry, a decade of wrong-head immigration policies coupled with a waning American interest in science has begun to jeopardize the US dominance in the life sciences. Further these trends are largely responsible for the massive layoffs and unrelenting outsourcing of pharmaceutical R&D jobs to foreign countries.

Toothless or not, the Invest in America Alliance shows that engineering and technology industry leaders are willing to cooperate with one another and get behind an initiative that raises public awareness about America’s waning competitiveness in these fields. Perhaps,   pharmaceutical, biotechnology and medical devices and diagnostic companies ought to take a page out of the Alliance’s play book to similarly insure the future innovation and competitiveness of the American life sciences industry.

Until next time...

Good Luck and Good Job Hunting!!!!!!!!!

• Email This
• Print
• Comments
• Trackbacks
• Share Link

As the competition for traditional life sciences jobs continues to intensify, many PhD-trained life scientists are looking for alternate career opportunities. One of the most popular and intriguing options is business—mostly because each of us more than likely knows somebody “who hit it big” by starting a biotechnology or life science-related company. While the entrepreneurial life isn’t for everyone, those intrepid individuals who are willing to give it a shot and possibly be successful ought to be aware of a few basic tools that will make life as an entrepreneur slightly less stressful. To that end, Emma Taylor over at Accredited Online Colleges sent me a blog post that lists 100 web tools that may be valuable to budding entrepreneurs and business-oriented life scientists.

Author Note: The list is a very valuable one; I am using several of the tools on the list that I had previously never heard about! So, here goes: 

Organization

Keep your studies, ideas and research organized with these helpful online tools.

1. Google Reader: Instead of visiting every blog you read, why not organize them all on this easy-to-use RSS reader?
2. Backpack: Keep your notes, contacts, information and just about everything else for class or business organized with this tool.
3. Stickies: This application makes it simple to make notes to yourself right on the web.
4. Bla-Bla List: Try out this to-do list application for no frills tracking of all the things you need to get done.
5. Mindomo: This web tool is great for laying out your thoughts for anything from business endeavors to class projects.
6. FreeMind: Use this free mind-mapping software to figure out where you want to go with an idea.
7. bubbl.us: This web application is perfect for brainstorming your next big project.
8. iOrganize: Mac users can try out this application, designed to keep notes and important information centrally located and easy to find.
9. Zoho Planner: Give this free planner a try. It’ll let you create and share to-dos, notes, contacts, images and more.
10. Clipmarks: Those who do a lot of web research or just like to browse can save interesting links for future reference using this tool

Scheduling

Make sure you never miss a meeting, test or networking opportunity by using these scheduling apps.

1. Google Calendar: Google’s calendar is easy-to-use and will let you organize all your important work, school and social events.
2. Cozi: This calendar tracks everything from sports meets to shopping lists.
3. Keep and Share: If you often work with others on projects or extracurricular activities, this calendar-sharing app could be right up your alley.
4. Spongecell: With this application you can create and customize your calendar and share it with others when you choose.
5. Doodle: This personalized scheduling app will help you arrive on time and prepared for the events in your life.
6. StudyRails: Plan out your study time and know when important due dates are coming up with this application.
7. 30 Boxes: Use this tool to keep track of all the things, both big and small, going on in your life.
8. SlimTimer: Track how long you’re working on a project, create to-dos and generally manage your time more wisely with this application.
9. WhichTime: This calendar makes it incredibly simple to keep track of where you’re supposed to be and when.
10. Jotlet: Quickly jot down appointments and important due dates using this calendar app. 

Networking and Marketing

Use these web tools to get your name out there, make connections and make the most of the millions of potential investors and employers using the web.

1. Facebook: You can do a whole lot more with Facebook than just keep track of your old friends. Create a networking profile and get your name known.
2. Twitter: Creating a Twitter account can be a great way to share updates about your business, school or your ideas.
3. LinkedIn: Take advantage of this networking tool to get in touch with the thousands of other businesspeople online in your field.
4. Elance: Using this tool you can make connections and even find some freelance work.
5. iMantri: If you’re in search of a mentor in your industry, don’t pass up this excellent site for pairing young professionals with mentors.
6. Company of Friends: One of the earliest business social networks, this site still offers a great number of professional contacts for those who are willing to search for them.
7. Ecademy: Meet people, blog and join professional groups on this business networking site.
8. Media Bistro: This site makes it easier to meet and talk with people in the content generation business, great for promoting your business or for making contacts.
9. Jigsaw: Link your budding business up with others through this large B2B network.
10. Meetup: Through this site you’ll be able to find business meetups, events and more in your area. 

Staying Connected

Talk to business partners, clients, friends and colleagues using these great online tools.

1. Gmail: Of the free email services out there, most would agree that Gmail is far and away the best choice. Better yet, you can link it up with a calendar, RSS reader and more.
2. Google Voice: This online service allows you to get your voice messages no matter where you are and to consolidate your phone numbers.
3. Campfire: Collaborate with others on school and work projects using this site.
4. FaxZERO: Fax machines may be outdated, but in your business you’ll likely encounter someone who wants something faxed to them. That’s where this service comes in handy.
5. K7: On the flipside, this service allows you to receive fax messages even if you don’t have a fax machine.
6. LogMeIn: If you can’t always take your computer with you where ever you go, it’s not a problem with this service that lets you log onto your desktop from anywhere.
7. Highrise: This web tool makes it simple to keep track of your professional contacts, perfect for helping you find work or drum up business.
8. Wufoo: One way to generate a better product is by asking customers what they think. This site helps you do that simply and easily.
9. Wordpress: What better way to get your business out there and stay connected with the world than by creating a blog? Get a free site here.
10. Meebo: Chat with people on all chat platforms using this one easy tool.

Research

Whether you’re doing research for a class or for your own ideas or ventures, these tools can help.

1. BNET: Get access to this site’s business library and news to stay on top of what is going on in the business world.
2. Seeking Alpha: Research stocks and investing ideas through this site.
3. U.S. Business Reporter: On this site you’ll find information about businesses, including their sales, statistics and more.
4. BizShark: Whether you’re looking for a job or just want to know more about a particular business, this search engine makes it simple.
5. Motley Fool: Find all the market advice and information you need through this site.
6. Masterseek: This company search engine lets you search by brand, product or business.
7. Zibb: Find just about any business and accompanying news, stats and information on this site.
8. Google Scholar: The web is full of information, but not all of it’s reliable. This search engine pares down results to just scholarly and professional sources.
9. Zotero: If you use Firefox as a browser, then try out this great plug-in that makes it simple to save, share and cite references you’ve culled from the web.
10. CiteULike: Make sure your bibliography isn’t a total mess by using this easy citation generator.

Mobile Apps

Don’t let a little thing like being away from the computer slow down your business aspirations. Try out these mobile web apps to take your projects on the road.

1. Business Reference Library: Make every time you don’t know something an opportunity to learn more with this amazing dictionary.
2. Oxford Dictionary of Finance and Banking: Look up any words or terms that seem strange to you with this handy tool.
3. mbPointer: Transform your phone into a fully featured presentation pointer using this application.
4. Analytics App: See just how well your business or personal website is doing with this analytics tool.
5. QuickOffice Mobile Office Suite: Whether you’re writing a business plan, tracking your finances or just preparing for class, this app lets you do it from anywhere.
6. Pocket MBA Test: If you’re studying to get your MBA, practice the information you’ll need to know for the test while on the go.
7. Glossary of Business Acronyms: Never wonder what an acronym means again with this helpful reference app.
8. Leadership Quotes: Get inspired with this application full of great business leadership quotes.
9. Bump: With this application you can share your business card simply by touching your phone to another.
10. Wall Street Words: Not sure what the heck the Wall Street Journal is talking about? Don’t stay ignorant, look the word up in this financial dictionary app.

Multitasking and Productivity

Learn how to get more done with less by using these apps.

1. OmniFocus: Try out this application to finally "get serious" about productivity with functions that let you take notes, turn them into to-dos and stay on task.
2. Netvibes: Keep all your favorite websites organized in one place so you can see what’s going on with each at the same time using this site.
3. Evernote: Create notes for yourself on the go and share, email and access them later with this tool.
4. Remember the Milk: Get to-do lists on your computer that you can check on the web or on your phone with this tool.
5. Ta-Da List: This simple tool lets you create to-do lists to ensure you get all your work done.
6. Joe’s Goals: Set goals for yourself for this year, five years from now or this week using this site.
7. Time Tracker: This tool lets you keep track of what sites you’re visiting so you can pare down your procrastination time.
8. Rescue Time: If you’re easily distracted, this tool is designed to help you focus and limit the temptation to browse other websites.
9. TreePad Lite: Organize your personal information, data, contacts, notes and more in one place using this application.
10. Todoist: Use this application to track all of the things you need to get done in a day or week.

Starting a Business

If you’re feeling ambitious and want to start your own business while in graduate school, these free tools can be a big help in getting the venture off the ground!

1. Highrise: Use the website to track business leads, clients and contacts so you’ll never lose out on potential business.
2. Freshbooks: Manage all of your business finances using this online tool.
3. Basecamp: This project management site will let you dole out tasks, see where a project stands and keep it all organized.
4. Wesabe: Whether you use it for your personal finances or to track a business’ worth, this free financial tool is a great online resource.
5. ConceptShare: Get feedback on your designs, concepts and projects easily through this collaborative tool.
6. PayPal: You’ve got to get paid somehow, and this site makes it pretty darn simple to get it done.
7. MyNewCompany: Use this site as a great source of information to make sure you’re not making any big blunders when it comes to running your new business.
8. Nolo: Find legal advice for your new business on this site.
9. BigCartel: If you need a shopping cart app for your site, this one is reasonably priced and easy to use.
10. Google AdWords: Google Ads are a great way to promote your business or to make a few extra bucks by placing them on your site.

Markets and Investment

Follow global economic trends, identify investors or and try your own hand at investing by using these tools.

1. Covestor: Follow what more experienced investors are doing on Covestor to see how things work and gain confidence.
2. Tip’d: Stay current with the latest business and financial news on this site.
3. Market Watch Community: This site will help you to learn more about the market in an online investment community.
4. Zopa: If you need a loan for your business, get one from everyday people and not the bank through this site.
5. Market Watch: Keep up with the ups and downs of the market on this site.
6. Quote.com: Find out where any stock stands by looking it up on this site.
7. Investor Guide: Get stock quotes, investing advice and the latest financial news on this site.
8. Go4Funding: Go through this site to find an angel investor for your business venture.
9. Venture Worthy: Find out if your business has what it takes to draw in investors from this great website.
10. Investing Minds: Share advice and ideas on investing on this online community.

Business Toolkits

These toolkits combine a wide variety of resources from business plan templates to financial calculators to make sure you know the ins and outs of being an entrepreneur.

1. Inc.com: From finding a job to managing a workplace, this site is full of tools and articles to help you do it right.
2. BizToolkit: Learn how to plan, market and grow a business with this toolkit.
3. Entrepreneur.com: Find vendors, learn how to franchise, discover PR tools and more through this site.
4. SCORE: Here you’ll get access to business-related quizzes, podcasts and links.
5. U.S. Small Business Administration: There are numerous free resources available to small business owners on this government site.
6. Bplans.com: Find sample business plans and learn how to build your own on this site.
7. Green Business Guide: Try out the resources found on this site to launch your own green business.
8. Small Business Toolkit: The U.S. Chamber of Commerce has created this set of tools to help you start, manage and expand your business.
9. Goliath Business Tools: With business plans, a business encyclopedia, and a company profile database, this site is chock-full of business goodness
10. Business Owner’s Toolkit Find everything you’ll need to get your business up and running on this site.

Until next time...

Good Luck and Good Job Hunting!!!!!!!!!!

• Email This
• Print
• Comments (1)
• Trackbacks
• Share Link

Carl Ichan, the billionaire, activist investor notified Genzyme that he will seek shareholder approval to seat four handpicked directors including himself to be appointed to the company’s board of directors in an attempt to remove embattled Chairman and CEO Henri Termeer who has led the company for the past 25 years.

The move was widely anticipated by industry analysts because Icahn own one percent of outstanding shares of Genzyme’s stock.  Icahn and other large shareholders believe the company would be better off under new leadership. Termeer has publicly stated that he has no intention of resigning.

Until recently, Genzyme’s standing and reputation in the biopharmaceutical and orphan drug industry was second-to-none. However, the company’s inability to quickly correct ongoing manufacturing problems at its biomanufacturing facilities for the past year has been extremely embarrassing and costly. Sloppy manufacturing and quality control problems this past year led to major shortages of two main products, Cerezyme and Fabrazyme. Consequently, in 2009 sales revenues dropped and company earnings were almost flat. Further, Genzyme shares lost 26% of their value in 2009, sinking to a five-year low.

Icahn is no stranger to hostile corporate takeovers and company sales. In spring of 2008, he unsuccessfully tried to gain control of the Biogen/Idec board to force the sale of the company (Ichan owns 5.6% of Biogen/Idec’s outstanding shares). Later that year, Icahn engineered the sale of ImClone to Eli Lilly for $7.0 billion; after getting into a very public and often acrimonious fight with Bristol-Myers Squibb CEO Jim Cornelius who tendered a “low-ball offer” (according to Icahn) to purchase ImClone.

According to my calculations, Icahn is batting .500 for his recent corporate takeover attempts. Do you think he will be able to go 2-for-3? I bet Henri Termeer is hoping that he can’t!

Until next time...

Good Luck and Good Job Hunting!!!!!!!!!!

• Email This
• Print
• Comments
• Trackbacks
• Share Link

Mary Canady author of the Comprendia Blog recently analyzed the popularity (or lack thereof) of a number of social networking sites that were created for life scientists. It would seem that online social networking sites would be ideal for scientists because we are not known for our networking or social communication skills in real life. However, only a few of the more than 15 life sciences social networking sites started in the past two years are doing well based on the traffic and usage statistics cited by Mary in her post. 

While Mary’s analysis included most of the well known life science social networking sites, she failed to include BioCrowd, the networking site started by Vincent Racaniello and me. While BioCrowd does cater to life scientists, we intentionally expanded our network to include other bioprofessionals including medical writers, marketers, consultants, venture capitalists and even CEOs! After all, it takes a village to take an idea from concept to commercialization.

Hat tip to Mary for the insightful post!

Until next time...

Good Luck and Good Job Hunting!!!!!!!

• Email This
• Print
• Comments
• Trackbacks
• Share Link

Amy Bishop, a tenure track faculty member of the Biology Department at the University of Alabama-Huntsville shot and killed three faculty members and wounded three others after learning that her appeal of a negative tenure decision was denied. While this incident doesn’t typify the response of faculty members who are denied tenure (subsequent reports suggest that she previously accidentally shot and killed her brother 20 years ago), it illustrates how high the stakes are or (may be perceived) by those aspiring to successful academic careers. 

Based my own experiences, being denied tenure is emotionally debilitating—mostly because of the public humiliation and stigma associated with it. Despite what your friends, loved ones or fellow faculty members say to you to ease the pain, being denied tenure suggests that you weren’t scientifically astute or “smart enough” to be guaranteed a job for life. It doesn’t matter whether or not the decision was fair or that there may have been extenuating personal or political circumstances, the bottom line is that you had your shot (no pun intended)and you simply didn’t have the right stuff to gain membership into the elite club populated by “outstanding scientists.” Put simply, your failure to win tenure has earned you the label of being a “failed scientist.” While nobody will ever utter those words, I can assure you, based on my own experiences that they think it no matter how successful you ultimately may become.

If I sound bitter...well....I am; but not for the reasons that you may suspect (being denied tenure was probably best career move that I was ever forced to make). While being denied tenure at institutions like Harvard, Stanford, Yale, Columbia or other elite universities doesn’t mean that you cannot have a successful academic career at lesser institutions, being denied tenure the University of Miami School of Medicine (or the University of Alabama-Huntsville for that matter) almost always means that your academic career is over. This means that after chasing an academic career for most of your professional life, you can longer do what you were trained to do and you must now do something else with your life Unfortunately, and not surprisingly, the vast majority of graduate students and postdocs that I have talked with over the past 15 years have given little thought to what that something else may be.

But, don’t be too hard yourself because you have no idea what you next career move may be after the academic career route path is no longer viable. The blame for this conundrum falls squarely on shoulders of the faculty members (mostly tenured) who train graduate students and postdoctoral fellows for careers in the life sciences. Despite the fact that only 10 percent of PhD-trained life scientists land tenure track positions after completing their training, graduate programs continue to exclusively focus on academic careers for their graduates and trainees. While I believe that this practice is ill-advised and clearly flies in the face of supply side economics, the steadfast refusal of life sciences graduate programs to develop alternative career tracts within their training programs to accommodate the career needs of a majority of their graduates is especially egregious and odious.

It is not difficult to understand why many tenured faculty members don’t give much thought about future employment prospects for their graduate students and postdocs. After all, they already have jobs that are guaranteed for life and it stands to reason that the careers and employment opportunities for others are not high on their priority lists.  Like it or not, when it comes to employment opportunities and career choices, most graduate students and postdocs are on their own!

It is extremely tragic that three people lost their lives and several others were wounded by a deeply troubled and misguided former tenure track faculty member. It won’t be surprising if certain faculty members dismiss the incident and attribute its horrific nature to a seriously disturbed and deranged person. After all, who in their right mind would do such an awful thing? However, I am certain that the humiliation, outrage and psychological pain experienced by Bishop are fairly common among individual who are denied tenure. Rather than turn her rage inward, she decided to take it out on the people who she thought had destroyed her life.  Maybe this incident will induce graduate programs to consider implementing career development programs that showcase alternate careers beyond the traditional tenure track career path.

Until next time...

Good Luck and Good Job Hunting!!!!!!!!

• Email This
• Print
• Comments (2)
• Trackbacks
• Share Link

In previous posts, I have mainly focused on job search strategies and behaviors designed to increase the likelihood of either getting a face-to-face job interview or a job offer. 

Today, I want to focus on behaviors and strategies that jobseekers must AVOID at all costs during a job search. In a CareerBuilder.com poll, more than 3,000 hiring managers and human resources professionals were asked to identify some of the more egregious mistakes that jobseekers (most notably recent college graduates) making during the application and interviewing process. Poll results per centages and associated commentary and advice were originally posted on the Pongo Resume blog.

1. Acting bored or cocky (69%)
This sounds familiar. We had someone interviewing at Pongo recently who seemed pretty good, but two or three people used the word "cocky" to describe the person's attitude. (Our managers, like those at many companies, solicit opinions from everybody who comes in contact with a job candidate, not just those in the interview room – hint, hint.) If you're a new college graduate, it's important to realize that you may have been the coolest kid on campus a few months ago, but today you’re an unproven beginner. A positive, respectful attitude is one way to set you apart. Confident = good. Cocky = bad.

2. Not dressing appropriately (65%)
Your interview attire, like your attitude, says a lot about whether you're serious about proving yourself, or just think you're entitled to the job because you're you. Your clothing should be clean, pressed, and modest. As they say in middle school, no visible boxers, bellies, or boobs.
 
3. Coming to the interview with no knowledge of the company (59%)
There's no excuse for not researching an organization that's considering hiring you. They have a web site; use it to learn what they do, who they are, what they specialize in. Google the executives' names (after all, they'll be Googling you; see #8, below). 

4. Not turning off cell phones or electronic devices (57%)
Frankly, I'm surprised this isn’t No. 1. If you accidentally leave your phone on and it rings during the interview, don't get flustered and start babbling, "OMG, I can't believe I did that!" Offer a brief, sincere apology, turn off the phone (without checking who it is), then carry on professionally as if nothing happened.

5. Not asking good questions during the interview (50%)
If you don't ask anything, you must not be interested. That's what the hiring manager will assume. This is a place where you supposedly want to spend most of your waking hours for the next couple years or more. You must want to know something. Besides, there are certain questions you should always ask.

6. Asking what the pay is before the company considered them for the job (39%)
Mentioning salary in a first interview is like asking your crush what s/he plans to spend on you during your relationship – before you've even agreed on a second date. You have to flirt and make sure they're attracted to you before you ask about a financial commitment.

7. Spamming employers with the same resume and/or cover letter (23%)
This guy John really, really wants to work for Company A, so he applies for every job opening Company A posts, whether he's qualified or not. Annoyed by John's never-ending resume spam, Company A's recruiters unofficially blacklist him (although if asked, they'll deny it). Don't be like John. Tailor your resume for the one or two jobs at your target company that align with your skills.

8. Failure to remove unprofessional photos/content from social networking pages, Web pages, blogs, etc. (20%)
Dude, you will be Googled. Employers today use every means at their disposal to uncover red flags that might foretell a bad hire. So, hide all Internet evidence of your past (and present) indiscretions.

While many of these not-so-smart behaviors may appear to be obvious, the percentages of new jobseekers who engage in them would suggest otherwise. The job market is extremely tight at the moment and the competition for jobs is the fiercest it has been in last 50 years. Don’t give hiring managers an excuse to not hire you by engaging in the above mentioned behaviors and practices!

Until next time...

Good Luck and Good Job Hunting!!!!!!!!

• Email This
• Print
• Comments
• Trackbacks
• Share Link

GlaxoSmithKline (GSK) Britain’s largest pharmaceutical company today announced it plans on slashing 4,000 jobs over the coming months. The bulk of the cuts will be in America and Europe, and are part of the company’s efforts to shift resources away from low-growth territories into parts of the world with greater scope to expand sales, most notably Asia. GSK’s currently employs 99,000 workers worldwide. The reduction in headcount will be combined with a drive to make the company’s research and development more cost-efficient. 

While the job losses will not be as severe as those announced last week by its rival Astra Zeneca, they will provide further depressing news for a sector that is fighting to contain costs as it reduces its reliance on big-selling blockbuster drugs, many of whose patents will expire in the next two to three years.

The pipeline of new drugs at GSK is much deeper than at many of its rivals, say industry analysts. The company’s roster of planned launches includes Menhibrix, a vaccine to combat meningitis, and Benlysta (belimumab), a novel, monoclonal antibody treatment for systemic lupus erythematosus that it is co-developing with Maryland-based, Human Genome Sciences. In total, the group has more than 30 products in the advanced stages of development and testing.

While GSK continues to develop new drugs, it has increasingly been turning to emerging markets to find and sustain corporate growth. This has meant that thousands of jobs have already been sacrificed in the West, although the company is adding staff elsewhere. For example, it recently cut 2,000 sales jobs in America but added 1,500 staff in China. Also, GSK’s vaccine division has suffered a few regulatory setbacks with its pneumococcal vaccine Synflorix and its cervical cancer vaccine Cervarix. The loss of market share in these areas has put additional financial pressure on the company.

Like many of its competitors, GSK is looking to other divisions of the company to cover projected losses in the pharmaceutical sector. Recently, GSK has shifted a lot of its attention to its consumer products division, which owns brands such as Lucozade and Ribena soft drinks, Aquafresh and Sensodyne toothpaste, and over-the-counter medicines such as Panadol painkillers and Alli, a weight-loss pill. Analysts predict the division will have raised its annual sales 18% to £4.7 billion. A deal signed last year to increase sales of Lucozade in China has provided the blueprint for how the company would like to develop the consumer healthcare side of its business.

Similarly, last week, Sanofi-Aventis, a French rival, announced a joint venture with Minsheng Pharmaceutical Group, a Chinese company, to sell vitamin pills and nutritional supplements. Also, Pfizer recently announced it would bid for the possibility of purchasing the financially-troubled German generics manufacturer Ratiopharm; signaling the possibility that the world's largest branded pharmaceutical manager may be toying with the idea of getting into the generics business.

Late last year I predicted that more pharmaceutical company employees would loss their jobs. Sadly, this prediction has come true. That said, I am surprised at the scope and size of the layoffs that have already taken place in 2010. I suspect that more layoffs are likely in the near future if the economy doesn’t turn around anytime soon.

Hat tip to Ed at the Pharmalot blog!

Until next time...

Good Luck and Good Job Hunting (try medical devices or biotech)!!!!!!!!

• Email This
• Print
• Comments
• Trackbacks
• Share Link

I Am Biotech, the Biotechnology Industry Organization’s (BIO) outreach program is trying to promote the use of social media to spread the word about the importance of biotechnology and how it has changed the world for many individuals.

BioCrowd was invited to contribute to the social media section of the website. Like us, I Am Biotech believes that social media has an important role in promoting a better public understanding of biotechnology and other aspects of the life sciences industry.

Please check us out and learn more about the value of becoming a member of the BioCrowd by clicking here.

Until next time

Good Luck and Good Surfing!!!!!!!!!!!

• Email This
• Print
• Comments
• Trackbacks
• Share Link

Have you ever found yourself in a situation where you needed important biological, genetic or other life sciences information quickly? Sure, you can Google the topic but it takes time to wade through all of the search results until you find the right one!

Carol Brown from Onlineuniversities.com sent me a list of the “100 Best Reference Sites for Science Students.” The list contains information for chemistry, environmental science and even geology.  I extracted the life sciences websites from the list and posted them below.  

1. Biology Online: On this site you can post questions in a forum, look things up in a bio dictionary, and read all kinds of informative articles and tutorials.
2. Everything Bio: Check out this resource to find a glossary, textbooks, images and a range of other online biology tools.
3. Life Science Dictionary: Try out this dictionary to look up life science terms and identify their meanings.
4. Molecular Biology Glossary: Students of molecular biology will appreciate this valuable research tool.
5. National Biological Information Infrastructure: Want to know and read about the research being done in the life sciences? Check out this site.
6. Biology Reference: You can look up loads of helpful biology terms in this online encyclopedia.
7. Biology Nation: From finding the best biology grad programs for looking up biology terminology, this site is a one-stop resource.
8. Dictionary of Cell and Molecular Biology: Search through this online dictionary to refresh your memory on the parts of the cell.
9. BioScience: With a dictionary, encyclopedia, links, software, and custom search tools, you’ll find more reference material than you could ever need on this site.
10. All Experts: Biology: Have a biology question you just can’t seem to find the 
11. Amino Acids Repository: Use this site as a reference on amino acid properties alone and in proteins.
12. Table of Standard Genetic Code: This site is a great reference when trying to remember which part of DNA goes where.
13. Talking Glossary of Genetic Terms: Don’t know how to say a particular term? No worries, this glossary will tell you and more.
14. Human Genome Acronym List: Don’t have a clue what the ASHG is? This site can help you look it up.
15. Genetics Resources on the Web: Search through this site for the best genetics resources the web has to offer.
16. National Human Genome Research Institute: This site offers a number of helpful educational resources for students young and old.
17. Genetics Virtual Library: Search by organism or topic to find the genetic information you need to do your homework.
18. Genetics Home Reference: Those studying genetic disorders will appreciate this quick online reference for conditions.
19. GeneTests: Even if you’re not in medicine, you’ll be able to find interesting and compelling information on this site.
20. Gene Cards: You’ll find a collection of concise information on just about every gene out there on this site.

While I can’t vouch for the quality of the  list, it looks to be pretty informative.

Until next time...

Good Luck and Good Studying!!!!!!

• Email This
• Print
• Comments
• Trackbacks
• Share Link

Politicians, educators and business leaders love to complain about the America’s dwindling competitiveness in math and science and the growing lack of innovation that seems to be pervasive among many American high school and college-aged students. This is the same mantra that I have been hearing for the past 20 years. Unfortunately, while the powers at be like to complain about these things, no government agencies, educational groups or private sector businesses seem to be able to come up with approaches or solutions to these problems (talk about lack of innovation!). 

Luckily, as Thomas Friedman pointed out in an Op-ED in this past Sunday’s New York Times, there are individuals and not-for-profit entities that have come up with two possible approaches to improve science and math preparedness and American innovation. 

The first of these novel ideas is called National Lab Day (NLD). It was introduced last November by a coalition of educators and scientific and engineering associations. NLD’s goal is to inspire future scientists, engineers and innovators by pairing experienced scientists and engineers with students in grades K-12 to work on hands-on science project around the US. Participating organizations that have pledged support for NLB include pledged support for National Lab Day are the John D. and Catherine T. MacArthur Foundation, the National Science Teachers Association, the National Science Foundation, the Bill and Melinda Gates Foundation, the Jack D. Hidary Foundation, the American Chemistry Society, the National Institutes of Health; and the Business Roundtable.

Conspicuously absent from the list are large organizations like the American Association for the Advancement of Science, the Federation of American Societies for Experimental Medicine, the American Society of Microbiology and others. Moreover, no academic institutions or research foundations or life sciences companies have offered to participate. See what I mean about lots of complaining and no action? To learn more about the program or offer support visit NationalLabDay.org. 

Another program that Friedman mentioned was the Network for Teaching Entrepreneurship or NFTE. NFTE works with middle and high school teachers to help them teach entrepreneurship. The centerpiece of the program is a national contest for start-ups with 24,000 low-income students participating. Each student has to invent a product or service, write up a business plan and then implement it.

While the scope of NFTE is limited to only low income students, I learned first hand what an important skill entrepreneurship is on the world stage. In the early 2000s while working as a management consultant, I was invited to dinner by the CEO of an Australian life sciences company. During dinner, I candidly asked her why an Australian biotech company was interested in hiring an American as a management consultant. She told me that while Australians do great science they are awful when it comes to translating the science into a viable business. “We simply don’t have the entrepreneurial understanding and spirit that most of you Americans seem to have. Our society doesn’t focus on individualism and innovation, we like to maintain the status quo” she said. After the meeting, I realized that we Americans take our entrepreneurial skills for granted and if we can no longer excel in this area than the US is truly doomed.

Finally, since this post is about science literacy and improving the public understanding of science, I wanted to mention a cool website called Sense About Science that you ought to check out. Although it is a UK-based organization, what it is trying to promote has global relevance. According to the website:

“Sense About Science is an independent charitable trust promoting good science and evidence in public debates. We do this by promoting respect for evidence and by urging scientists to engage actively with a wide range of groups, particularly when debates are controversial or difficult.

We work with scientists to

• respond to inaccuracies in public claims about science, medicine, and technology
• promote the benefits of scientific research to the public
• help those who need expert help contact scientists about issues of importance
• brief non-specialists on scientific developments and practices

Sense About Science is governed by a Board of Trustees and run by a small office staff. We are supported by an Advisory Council and over 2,000 scientists and other specialists, ranging from Nobel Laureates to postdoctoral fellows, who are signed up to our database, Evidence Base. We also work with younger scientists in our VoYS (Voice of Young Science) programme, which you can read more about here.”

Until next time....

Good Luck and Good Learning!!!!!!!!

• Email This
• Print
• Comments
• Trackbacks
• Share Link

Let’s face it; scientists aren’t generally regarded as being funny. While I have met several very funny researchers during my almost 35 year career, the vast majority of my colleagues have been mostly serious and, at times, difficult to amuse; especially when things weren't going so well in the lab.

I consider myself to be a funny guy. And, hanging out and playing softball with Larry David, co-creator of Seinfeld and star of Curb Your Enthusiasm, for three years while a postdoc at Columbia Medical School convinced me that I have some talent. However, while I have often fantasized about a career in comedy, I never had the courage to turn in my lab coat and give it a try. The same can't be said about Tim Lee; a card-carrying PhD-trained biologist who after realizing laboratory research wasn’t for him decided to embark on a career as stand up comedian.

While Powerpoint presentations (modeled after scientific seminars) serve as the centerpieces of his stand up routines, Tim is also exploring other comedic vehicles to help him continue to make a living as a stand up comic. As he told BioCrowd co-founder Vincent Racaniello and I in a recent podcast that we did with Tim before a mid-week stand up gig in San Francisco, 'you gotta lead with your strengths."

Tim has been working as a comedian for the past seven years and, much to his surprise and pleasure, is "making more than he would have if he had chosen to do a postdoc after completing his PhD degree." Tim's star is rising and was recently featured in a New York Times article entitled “Did You Hear the One about the Former Scientist.”

Vincent and I had a wonderful discussion with Tim about his difficult decision to abandon science and what it feels like to embark on a new career (that you didn’t spend 10 years training for!) He still takes science seriously and frequently peruses journal articles and other scientific sources for material. And, for the record both Vincent and I thought Tim was pretty, pretty good (as Larry David would say) at what he does!.

To listen to the podcast and to see a video of one of Tim’s stand up routines visit BioCrowd!

Until next time...

Good Luck and Good Job Hunting (the comedy clubs can use a few more good scientists)

• Email This
• Print
• Comments (2)
• Trackbacks
• Share Link

Despite rumors of impending demise and premature death, the issues surrounding the use of social media in the life sciences industry are still alive and relevant. To that end, the Business Development Institute is sponsoring a “Healthcare Social Communications Leadership Forum Breakfasts on February 4, 2010 at New York University in Manhattan. The conference is limited to 75 attendees. While there are seats still available they are rapidly disappearing. 

Some of the topics to be discussed include:

• How to connect with consumers who are already using the internet for healthcare information?
• What are the case studies of leading brands that use internet based social strategies to achieve communications objectives?
• What are examples of social communities that demonstrate how leading healthcare brands interact, educate and provide value to consumers online?
• How to deal with regulatory and legal issues when planning and implementing social and internet based strategies
• Why real-time social media tools, such as Twitter, are gaining momentum and what's the business case to use them
• How to sell projects and prove ROI to senior management
• What are the tools, technologies, and best practices for monitoring and measuring internet based programs?

Scheduled presenters and panelists are:

1. Michael Fleming, Senior Director, Social Media, GlaxoSmithKline
2. Robert Halper, Director of Video Communication, Johnson & Johnson
3. Lance Hill, CEO, Within3
4. Ray Kerins, Vice President / Worldwide Communications, Pfizer Inc.
5. Marc Monseau, Director, Corporate Communications & Social Media, Johnson & Johnson
6. Rodney Spady, Head of Global Interactive Marketing and Web Officer, OTC Global Marketing, Novartis Consumer Health, Inc.

For more information, including registration, please click here to visit the event website. Use promo code BIOC before February 3rd for a discounted rate of $175.

See you at the meeting!

Until next time...

Good Luck and Good Job Social Networking!!!!!!

• Email This
• Print
• Comments (1)
• Trackbacks
• Share Link

While this isn’t a new topic, I wanted to raise the question again because I recently received a message  from a reader that greatly troubled me. The person who posted the comment has a PhD degree in biomedical engineering and is extremely angry with the existing system because of the lack of employment opportunities in her field. Put simply, she is so frustrated with the system that she no longer believes that it is ethical to advise young people to pursue careers in the life sciences. I know that she isn’t alone and that many of you share her anger and frustration with the lies (as she put it) about employment opportunities for life sciences PhD candidates and postdoctoral fellows

From time to time, I am invited by graduate students and postdoctoral fellows to talk about alternative careers in the life sciences. I try to remain upbeat and positive during my presentation but generally I can’t control myself by the Q&A session. Invariably, I rant and rave about how dysfunctional academia has become. Interestingly, I recently was uninvited by my former graduate department where I was slated to present a seminar on alternate career choices for life scientists. As the tenured faculty member (you know how I feel about tenure) who would have sponsored my visit told me “the seminars that we offer our students are scientific in nature and much different than many of the topics that I discuss on my very interesting blog.” Consequently, he informed me that I was no longer invited to give my talk (I was previously invited by the Department Chair who happened to be a former colleague of mine who decided to move to another institution before my visit). In an e-mail response to his un-invitation, I told him that I wanted to visit the Department and give the talk because I believe that my graduate education is what enabled me to maneuver the minefield that ultimately became my career path. Also, I told him that I wanted to share my insights and career experiences with current graduate students and postdoctoral fellows because I thought that many may benefit from them. Not surprisingly, I never heard back from him. 

The point that I am trying to make is that my message about alternative careers for PhD students is diametrically opposed to the mission of most PhD programs; which is to prepare 100% of their students for academic careers. Unfortunately, as I have stated many times in the past, only about 10% of those who receive life sciences PhD degrees land academic appointments. What are the remaining 90% of the folks who toiled long and hard for their PhD degrees suppose to do with their lives? In the past, as many as 50% or more of these students were able to garner jobs as research scientists at biotechnology and pharmaceutical companies or with government agencies like the CDC, FDA, EPA and others. Unfortunately, the pharmaceutical industry has laid off over 200,000 employees in the past 3 years, funding for biotech companies has hit an all time low and we are experiencing the worst recession in almost 70 years which is causing government agencies to stop hiring! This begs the question: what are graduate students pursuing PhD degrees and postdoctoral fellows suppose to do to put food on the table to feed their families and themselves? 

While I don’t have an easy answer to that question, I can tell you that getting angry and frustrated or dropping out of the system isn’t going to change anything. I will also tell you that the system isn’t going to change by itself! To that end, it may make sense for all of you angry and frustrated graduate students and postdoctoral fellows to band together and tell your advisors and mentors that “you are mad as hell and not going to take it anymore.” To show them that you are serious, I highly recommend that your offer them a plan to address your concerns about finding gainful employment (not decade long postdoctoral fellowships) following completion of your PhD degrees. For example, you may suggest that they add alternate career certificate and degree programs to their existing curricula. Or, if new programs are too costly, suggest that they offer courses that showcase alternate career options like entrepreneurship, science writing or medical communications. Finally, at the very list, insist that they work with local companies and organization to create sponsored internship opportunities and get them to commit to supporting annual career development symposia or job fairs for graduate students and postdocs.

For the past decade or more, I have struggled to convince many of my academic colleagues to consider any and all of the above suggestions. Unfortunately, my pleas for creation of new courses and programs have fallen upon deaf ears! Given my current lack of success, I suspect that it is going to take more than one person (me) to induce the academic establishment to consider systemic change. That said anybody who may be interested in joining the “cause” to improve employment opportunities for PhD life scientists, please feel free to contact me!

Until next time...

Good Luck and Good Organizing!!!!!

• Email This
• Print
• Comments (1)
• Trackbacks
• Share Link

Governor Deval Patrick and the Massachusetts Life Sciences Center announced today that the Center’s Board of Directors has awarded $25 million in Tax Incentives to twenty-eight life sciences companies. The companies receiving tax incentive awards have committed to creating a combined 918 new jobs in the Commonwealth over the coming year. The companies that received awards include many of state’s largest biotechnology companies e.g. Biogen, Genzyme, Sepracor and Cubist, as well as some smaller private and public ones (see below) 

1. Alnylam Pharmaceuticals, Inc. (Cambridge) — $300,000
2. Biogen Idec MA, Inc. (Cambridge) — $1,500,000
3. Constellation Pharmaceuticals, Inc. (Cambridge) — $513,252
4. Cubist Pharmaceuticals, Inc. (Lexington) — $1,740,000
5. Dyax Corporation (Cambridge) — $100,000
6. Facet Solutions (Hopkinton) — $300,000
7. FoldRx Pharmaceuticals, Inc. (Cambridge) — $510,000
8. Genzyme Corporation (Cambridge/Framingham) — $6,000,000
9. GTC Biotherapeutics, Inc. (Framingham) — $300,000
10. Hologic, Inc. (Bedford) — $220,000
11. Infinity Pharmaceuticals, Inc. (Cambridge) — $540,000
12. InfraReDx, Inc. (Burlington) — $630,000
13. Interlace Medical, Inc. (Framingham) — $300,000
14. Lightlab Imaging, Inc. (Westford) — $188,951
15. Merrimack Pharmaceuticals, Inc. (Cambridge) — $1,500,000
16. Morgan Advanced Ceramics, Inc. (New Bedford) — $570,000
17. NeuroMetrix, Inc. (Waltham) — $300,000
18. Nova Biomedical Corporation (Waltham) — $300,000
19. OmniGuide, Inc. (Cambridge) — $540,000
20. Organogenesis (Canton) — $245,240
21. Pharmasphere, LLC (Worcester) — $360,000
22. Sepracor, Inc. (Marlboro) — $750,000
23. Shire Human Genetic Therapies, Inc. (Lexington) — $6,277,057
24. STD Med, Inc. (Stoughton) — $121,000
25. Still River Systems, Inc. (Littleton) — $300,000
26. TEI Biosciences, Inc. (South Boston) — $27,000
27. Tolerx, Inc. (Cambridge) — $300,000
28. Zoll Medical Corporation (Chelmsford) — $267,500

While the tax breaks are a great way to insure that the 28 companies that received them will remain and continue to do business in Massachusetts, creation of only 918 new jobs in exchange for $25 million in tax incentives doesn’t seem fair to me! I guess beggars (state governments) can be chooser in the current economic climate.

Until next time...

Good Luck and Good Job Hunting (try MA, there may be one or two opportunities there)

• Email This
• Print
• Comments
• Trackbacks
• Share Link

Mark Senak, author of the EyeonFDA blog and “all around good guy,” has created a Twitter list that follows the tweets of all of the pharmaceutical companies that use Twitter. Because the list of companies that are currently using Twitter is so small, it is a convenient aggregation tool to monitor the musings and tweets of companies that participate! 

 Hat tip and shout out to Mark!

Until next time....

Good Luck and Happy Holidays!!!!

• Email This
• Print
• Comments
• Trackbacks
• Share Link

Mark Senak who writes the EyeonFDA blog has compiled a list of the life sciences companies that presently have a Twitter account and use it. While there are only 12 companies on the list, he provides a nice commentary on their use and makes some recommendations for improvement.

Although I am a staunch supporter of the use of social media in the life sciences, it appears to me that the discussion about its use has been somewhat muted since the FDA convened a public hearing on the topic last month. I suspect that many of the companies and stakeholders who participated in the discussion prior to the FDA meeting are presently in “wait and see” mode. However, don’t be surprised if the social media guidance issued by FDA is lacking and excruciatingly wanting!!!! For those of you who may not be familiar with the ways in which the agency operates, its regulators tend to craft guidance and regulation that are broad, loosely defined and open to interpretation. The agency intentionally crafts its guidance and regulations this way because it doesn’t want its rules and regulations to be “literally interpreted” by companies and other stakeholders. Generally speaking, its regulations represent the “minimum” requirements that must be met in order to insure regulatory compliance. In other words, there is no upper limit on what companies can do to insure compliance but there certainly is a minimum requirement that must be met to avoid regulatory sanctions and penalties. As one lawyer who used to work for the agency shared with me recently, “FDA crafts the regulations but it is left to the companies and courts to interpret them.”

Most of the current discussions about social media and the life sciences industry primarily focus on its use as marketing and promotional vehicle. And, as many of you may already know, FDA isn’t exactly keen or pleased with the current marketing and advertising strategies and practices utilized by a sizeable number of life sciences companies. Perhaps a shift away from marketing and advertising discussions to more regulatory-friendly and practical applications like clinical trials recruitment and public outreach may lead to a more rapid uptake of social media by FDA and life sciences companies? Just sayin’

Until next time...

Good Luck and Good Tweeting!!!!

• Email This
• Print
• Comments
• Trackbacks
• Share Link

I think the economy must be improving because I am beginning to receive e-mail blasts from big pharma companies like Roche and AstraZeneca that they are hiring again (Please see the e-mail message below).  This may be a good sign for R&D scientists who have been struggling to find gainful employment.

In the spirit of full disclosure I have never worked nor am I am employed by AstraZeneca and I am not being compensated for this advertisement. I am simply a nice guy trying to help out my fellow scientists (hmm, I recall hearing something about nice guys.....)  However, I must warn you that just because companies advertise that they are hiring doesn't always mean that they really are.  Please keep that in mind when you apply for positions that AZ is advertising.

New R&D career opportunities at AstraZeneca. At AstraZeneca, your research and development experience can make a world of difference. That's because you'll be a part of a leading global pharmaceutical company with one of the most influential portfolios of innovative pharmaceutical brands. We continuously challenge, discover and develop new medicines in order to improve the quality of people's lives. It's an ongoing quest that involves the talent, ideas and growth of all our professionals, as we strive to advance the future of healthcare. Today, we're seeking qualified candidates to join our passionate culture in our Research and Development area. It's your opportunity to utilize your expertise for a greater purpose, while you're supported every step of the way. We encourage knowledge, respect growth and believe that there's always more to learn. It's one of the reasons why you'll become colleagues with some of the most talented and experienced professionals in the industry. As part of the Monster research and development professionals network, we invite you to learn more and apply for one of our research and development opportunities today. Sincerely, The AstraZeneca Human Resources team Learn More & Apply If you would like to stay current on AstraZeneca, you can sign up to receive more information here: www.IWantToAdvanceMyCareer.com AstraZeneca is an equal opportunity employer.

Good Luck!!!!!

• Email This
• Print
• Comments
• Trackbacks
• Share Link

In a previous blog post, I raised the possibility that the life sciences industry may be using adverse event (AE) reporting to explain why it has been slow to adopt social media as a means of communicating and interacting with its customers and stakeholders. The industry argument against social media goes something like this: by engaging physicians, consumers and other stakeholders in social media conversations, there will be a massive and unmanageable explosion of AEs posted to social networking sites, company websites and health and science blogs. Because of this, companies will be obliged to report them to FDA. Company executives’ fear that this will be inordinately expensive, egregiously time-consuming, technologically-daunting and most importantly, expose companies to possible legal and regulatory actions. While some of these claims may have some validity, they are not as expensive, technologically-challenging or insurmountable as anti-social media advocate would have you believe. For example, while conducting an interview for Life Science Leader magazine for an article on social media and pharma, several pharma employees exploring the social media space confided that most companies already have assiduously-crafted AE reporting policies in place to easily manage and accommodate AE reporting from  websites, cell phones and even text messages! For those of you who may be wondering, before potential AEs are required to be reported to FDA it must meet the following criteria: (i) there is an identifiable patient; (ii) there is an identifiable reporter or observer; (iii) there is a specific drug or biologic involved in the event; and (iv) there is an adverse event or fatal outcome.

Jonathan Richman (social media guru and pharmaceutical marketing expert) and I have previously weighed in on the so-called “adverse event reporting myth” that has been circulating in life sciences social media circles. In fact, I posited in my previous post that adverse event reporting may actually be something of a “red herring” being used by the industry. For those of you who may not be familiar with the term, it means focusing on an obvious and easily identifiable issue or object to draw attention away from a more important central issue.  To that end, I was pleased to read a post today on Jonathan’s Dose of Digital Blog entitled 166 Reportable Adverse Events Equals One Red Herring.

In today’s post, Jonathan does some basic mathematical calculations and arrives at the conclusion (based on the occurrence and frequency of Internet-based adverse events disclosed in a recent Nielsen survey) that the likely number of adverse events posted on social media sites per day would be around 166 (for the entire industry). Doing some of my own high-level mathematical calculations; this translates into a likely total annual number of about 60,590 AEs. And, as Jonathan rightly points out, if this number is divided by the number of life sciences companies with approved drugs and devices on the market, you quickly realize that shouldn’t be that onerous, labor intensive or expensive for companies to manage AE reporting resulting from social media sources. It would be interesting and informative to compare this annual rate with the actual number of reportable annual adverse events being handled by life sciences companies today. 

Like Jonathan, I believe that the “adverse event reporting issue” is a classic example of a “red herring” being employed by the life sciences industry to explain its reluctance to jump on the social media bandwagon. Personally, what I believe is really at stake, is the systemic changes that would be required to transform a historically, opaque and unresponsive industry into a transparent, accountable and responsive one that would be required if it embraces social media as an integral part of its business model.  

Addendum:  Shortly after posting this article, a new post appeared on the Dose of Digital blog that provided an indepth analysis of the Nielsen survey and its implications.

Until next time...

Good Luck and Good Job Hunting!!!!

• Email This
• Print
• Comments
• Trackbacks
• Share Link

Losing a job or getting laid off is without a doubt one of the more emotionally devastating events that most people face. Unfortunately, in these troubling financial times, many more people are likely to face this likelihood than any other time in recent history.

However, if you lose or have lost a job, it is important to keep your situation in perspective and realize that it isn’t the end of the world and that there are things that you can do to find a new job! Having said that, like most other things in life you will have to work hard to achieve that goal! This will require organization, commitment and dedication to the job search. And, the best way to conduct a successful job search is to approach it and treat it like a full time job! To that end, attempt to divide each day into manageable list of tasks and allocate sufficient time to accomplish them—just like you would at a full time job. Also, since time is usually no longer an issue, you can spend some of your time researching new opportunities, networking with others or finding new contacts who might be able to help you get your foot in the door at a prospective employer’s company or organization.

Sitting in front of a computer all day, applying for online jobs on company websites and job boards isn’t going to cut it—mostly because you won’t hear back from most of the places where you submitted online job application. In fact, I think that the online approach to job hunting almost guarantees that you will become dejected, depressed and hopeless. 

In my opinion, the best approach to a job search (after losing a job) is to recognize that anything less than full time commitment to finding a new one likely won’t be successful. Based on my own and other’s experience, a successful job search consists of a mixture of focused and disciplined online and IRL activities. Developing and implementing an ordered and strategic job search provides jobseekers with organization and a “structure” that will likely help to ward off feelings of confusion, dejection and hopelessness experienced by most people who have lost jobs. For more ideas and suggestions on how to transform your job search into a full time job please check out this excellent article by Phyllis Korkki.

Until next time....

Good Luck and Good Job Hunting!!!!!!!!

• Email This
• Print
• Comments
• Trackbacks
• Share Link

In today’s edition of the incisive EyeonFDA blog, Mark Senak, provides a historical perspective on events leading to the US Food and Drug Administration public hearing on the use of social media and medical promotion that will be held on Thursday and Friday, November 12 and 13, 2009. As Mark points out, registration for the meeting was closed because of an overwhelming response and the number of people who wanted to offer testimony on the topic. Many social media enthusiasts view the public hearing as something of a “game changer” that may influence the future direction of social media in the life sciences industry. But, as Mark, astutely points out, only four pharmaceutical companies and one or two trade organizations will be participating at the hearing. 

The lack of industry participation at the meeting is curious given that 14 companies received warning letters several months ago about their misuse of ad associated with the results obtain by Google search. Further, pharmaceutical companies have consistently and publicly stated that their aversion to social media is contingent upon the lack of FDA’s regulatory guidance for its use. By not actively participating in the public hearings later this week, many pharma companies have chosen to remain silent and will likely allow FDA to craft social media policies that guide the promotional activities of drug makers on its own. This begs the question: why would drug makers allow a federal regulatory agency to unilaterally dictate policy, when the policy will likely affect their bottom lines, i.e. sales and profits? The industry’s refusal to actively participate in these hearings is another example of the cat and mouse game that drug makers like to play with FDA. Put simply, drug makers expect and want FDA to commit (in writing) to certain policies and guidelines and once established, company regulators and lawyers are instructed to find loopholes and work-arounds. I liken the drug industry’s refusal to actively participate in the upcoming public hearings to the now infamous rope-ad-dope strategy Mohammed Ali used to knock out George Foreman in the now infamous Rumble in the Jungle in 1974. This is how wikipedia defines the rope-a-dope: “The rope-a-dope is performed by a boxer assuming a protected stance, in Ali's classic pose, lying against the ropes, and allowing his opponent to hit him, in the hope that the opponent will become tired and make mistakes which the boxer can exploit in a counterattack.” I hope that I am wrong about the drug industry’s strategy and motives.

Without active industry participation it isn’t clear how effective the FDA public hearing on social media will be. As Mark adroitly points out in today’s post, “The bulk of the other presentations are tertiary stakeholders perhaps sensing a vehicle for free self-promotion such as advertising and public relations firms and bloggers, but they aren't the real stakeholders in this issue.  The real stakeholders are those who are referred to in the meeting notice - the medical products industry.” I would also add the American public to the stakeholder list who also has considerable “skin in the game.”

Pharma’s active participation at many of the social media conferences that I recently attended indicates that something must be in it for pharma; otherwise they wouldn’t attend. There is no question that social media isn’t a passing fad and is now an integral part of the Web 2.0 experience. That said, for the first time in many years, drug makers have a unique opportunity to actively voice their ideas and concerns and collaboratively work with FDA to craft meaningful social media regulatory guidance. As many of us “outside observers” know, the agency doesn’t have all the answers and we would like to think that drug makers would extend a helping hand to avoid confusion and misunderstandings about the use of social media to promote their products and services. While only 4 companies are scheduled to speak at the hearings, I suspect that there will be many life science company representatives in attendance. Nevertheless, despite what may happen at this week’s hearings, I hope that, going forward, drug makers and device manufacturers will begin to view FDA as a partner rather than an adversary!

Until next time...

Good Luck and Good Job Hunting!!!!

• Email This
• Print
• Comments
• Trackbacks
• Share Link

I just returned from the 2009 Annual Biomedical Research Conference for Minority Students (ABRCMS) that was held in Phoenix last week. I attended ABRCMS for the first time last year and decided that it was a meeting not to be missed in 2009. Once again the students (mainly undergraduate life sciences majors) were outstanding, knowledgeable and exceedingly professional—something that is frequently missing or absent in their non-minority counterparts. Like last year, every major academic institution, professional society and research organization attended the meeting to recruit minority students to their programs. However, despite the similarities to last year’s meeting, there were several noticeable differences that are worth pointing out.

First, the number of women undergraduate life sciences major who attended the meeting was substantially greater than the number of men in attendance. This shift is indicative of enrollment changes that are taking place in medicine, law and life sciences graduate programs where women now outnumber men. Second, many more students were seeking career development counseling and resume critiquing this year as compared with last year. This likely has much to do with the ongoing financial crisis and rising unemployment which now exceed 10% nationally. Third, many more students I talked with this year were interested in attending graduate school rather than medical school. This shift may have something to do with anticipated changes to the US medical profession that may result from healthcare reform. Alternatively, more minority students are interested in research as compared with medicine and related healthcare professions. 

Finally, the conference keynote address offered by Mae C. Jemison, MD a former astronaut and life science entrepreneur was one of the most inspirational and informative talks that I have ever heard about career opportunities in the life sciences. Dr. Jemison clearly articulated her belief that society ought to stop differentiating between artists and scientists. Further, she added that the two professions are not mutually exclusive from one another! This is likely because, she, in addition to her medical interests, is a professional dancer/choreographer and also a fashion designer. Coincidentally, earlier that morning I was talking with several female scientists who also happened to be life long dancers and choreographers.  I urged them to continue to draw on their dancing experience to channel that creativity to their research. It was humbling to learn that someone as successful and talented as Dr. Jamison shares many of my beliefs and ideas.

On the plane trip back to New Jersey, I happened to sit next to a young assistant professor from Princeton University who will likely earn tenure next year (he was invited to apply for an early decision). Like most other scientists, he initially challenged my notion that PhD students and postdoctoral fellows ought to be offered courses— or at the very least some information about non-academic careers—before they complete their training. After all, only about 10% to 15% of US life sciences PhDs are able to land tenure track positions upon completion of their training. Initially, many of his remarks were expected: “If you want a job you should go to medical school or law school or do something else...nobody said that getting a PhD would help you find a job” and “we train students for academic jobs because it is a way for us to ensure and preserve our legacy as scientists.” It was a good thing that I had my seat belt on at the time because I almost bolted out of my seat after hearing that!  I tactfully (which isn’t easy for me as those who know me will tell you) suggested to him that that kind of thinking is blatantly self-serving and extremely egotistical. Further, I suggested that it is ethically and morally disingenuous for tenured faculty members to continue to train students for jobs that they know don’t exist anymore.  Luckily, he is young and open minded and ultimately conceded that the system is kind of broken and perhaps things need to change. He also offered that he, (unlike most of the people who I trained with the exception of my PhD advisor) discusses career options with his students (some of whom aren’t interested in academic careers) and helps them in any way he can to realize their goals and dreams. Finally, I suggested to him that offering students and postdoctoral fellows some formal courses or training in alternate career options will likely have better performance and outcomes for students and faculty members as compared with continuing to keep them in the dark about career choices and job prospects.

While there is still much work to be done, it appears that younger faculty members are finally recognizing that traditional academic training paradigms may be anachronistic and changes may be necessary for the US to continue to train the best and the brightest!

Until next time...

Good Luck and Good Job Hunting!!!!

• Email This
• Print
• Comments (1)
• Trackbacks
• Share Link

Over the past year or so, more graduate students and postdoctoral fellows have been asking me about management consulting careers in the life sciences. I spent several years working as an independent management consultant and while it was a great experience the revenue stream was unreliable at best and the ability to work was highly contingent upon the economy. However, I can assure that my experiences as an independent management consultant were marketing different than those of consultants who work at the consulting firms like McKinsey or the Boston Consulting Group. For those of you interested in life style of a high-powered management consultant I highly recommend you visit their websites for more info. 

I invited Susan Colilla, PhD, MPH, President of the consulting firm Integrative Epidemiology LLC describe her experiences about becoming a life sciences consultant so that BioJobBlog job readers (who may be considering this as a career option), might get an idea and appreciate what it takes to get into and be successful in this line of work.

My Life as a Life Sciences Management Consultant

by Susan Colilla

After doing a second postdoc at University of Pennsylvania as an Instructor (nebulous junior non-faculty type position) and becoming frustrated with all the extensive work requirements for a tenure-track position, I started searching for a job in pharmaceutical industry.

While searching for a position, a potential employer, who didn’t have an opening at the time, asked if I would be interested in consulting.  As I was interested in this area, I started consulting for industry and realized that I enjoyed working on different projects in epidemiology and genetics, and loved that I could work from my home office and give up a commute. 

The flexibility in consulting is great.  I plan the work around my schedule, and the pay has been rewarding as well.  Last year, I formally incorporated my business, Integrative Epidemiology, LLC.  I offer services in literature reviews, study planning/design, data analysis and grant or manuscript writing in the areas of human genetics or epidemiology. 

As I build my business, I have learned about how to run a business, bookkeeping/billing, taxes, legal issues/contracts, and marketing.  Moving from academia to pharma/industry is tricky unless you have connections with those who hire in the industry.  One of the biggest challenges for me as a self-employed consultant is dedicating a good proportion of my time to networking with others and marketing my services, rather than doing science-related work.  It helps that I am very social by nature and enjoy meeting new people.

 I am also fortunate to be married to someone who makes a good income and receives benefits as this helps support our family.  There can be a sporadic flow of income with consulting, especially during a recession and new business slows down.  I have also partnered up with another consulting group (Venebio, LLC, based in Richmond, VA) to expand the pool of potential clients and work with a group of scientists to offer a broader range of services. 

For those of you who want to learn more about getting into the consultant business, Susan highly recommends an article that recently appeared in the Scientist. She shared with me that the article offers a great list of things to consider before starting a consultancy and that she “wished that she had seen it a couple years ago when I started out in this business!”

Until next time...

Good Luck and Good Job Hunting!!!!  

• Email This
• Print
• Comments
• Trackbacks
• Share Link

I received a call today from GDS International, a UK-based b2b publishing company, alerting me to its annual, event called the Next Generation Pharmaceutical Summit (NGP) currently taking place at the Ritz Carlton on Amelia Island in FL. This invitation only event is supposed to bring pharmaceutical and life sciences executives to discuss problems facing the industry and what thing ought to be implemented to insure continued progress and growth.   This is the news coming out of the conference attended by over 50 pharmaceutical and biotechnology executives

Big Pharma concludes that M&A is not the New R&D

With large firms seeking synergies to drive down R&D costs, M&A deals can aid in the transfer of technical knowledge, scalability and reduce time to market. However, previous M&A periods have not alleviated the productivity crisis. “While short term gains emerge from these deals, in the mid to long term, R&D innovation, organic growth, and internal drivers are still key facet’s behind creating a successful company and providing an organization with sustainability.” So says, an executive committee composed of  50 pharmaceutical executives including Jeffery Nye, Chief Medical Officer at Johnson & Johnson, Reinilde Heyrman—VP of Clinical  Development at Daiichi Sankyo, Oscar Laskin—VP of Early Development at Celgene are leading the debate, joined by Ann Wang—VP of Clinical Operations at Human Genome Sciences. These sentiments confirm the notion that the pharmaceutical and biotechnology industries are in transition and suggest that life sciences companies still face many serious challenges in the not too distant future.

While increasing mergers and acquisitions isn’t likely to reinvigorate R&D, newly emerging economic pressures have recently triggered another wave of M&A activity in both sectors. But is this the solution for long-term sustainable growth?  “The willingness for the industry to unite in such a way clearly demonstrates long-term strategies for improved business processes so long-term investment in R&D can be secured” said Drew Contessa the NPG director.

The NPG will reconvene in April 2010 to review recommendations and actionable items.

The realization that M&A is not a solution to correct waning productivity in R&D was a long time coming. It cost about 150,000 pharmaceutical employees their jobs over the past three years. The idea that companies are beginning to recognize that buying or merging with another company is not a panacea or long term fix is a good thing. 

Hopefully, the life sciences industry can learn from its past mistakes.

Until next time....

Good Luck and Good Job Hunting!!!!!! 

• Email This
• Print
• Comments
• Trackbacks
• Share Link

For the past several weeks, the EyeonFDA blog has been reporting on the possible regulatory impact of Google’s Sidewiki on life sciences companies. For those of you who may not be familiar with Sidewiki  (released in late September) it is a new feature of the Google toolbar which can turn a static web 1.0 website into an interactive web 2.0 experience by allowing website visitors to leave comments behind.

When you use side-wiki, you have the ability to leave your comments and associate them with a website whether or not the website owner has enabled commenting.  Since the comments are maintained by Google, there is no direct relationship with the website.  Basically, anybody who visits a website that has Sidewiki enabled can say or comment on whatever they like and immortalize it (until Google removes it) for the entire world to see. Apparently, this doesn’t sit well with many website owners and Google purportedly recently release code to disable Sidewiki at websites that don’t want to support it. However, it isn’t clear how robust the anti-sidewiki code is!

While I haven’t formulated an opinion on Side Wiki yet (mostly because it isn’t that interesting to me), it does represent a regulatory dilemma for life sciences companies with marketed drugs and devices. According to today’s EyeonFDA post “If someone writes of an adverse event on a Sidewiki, or promotes an off-label use, it is now on the company's home page.  Is the company under a duty to monitor and correct such misinformation or if they do, do they incur liability for doing so?  It is a conundrum - and there is no insight apparent from the FDA on the matter.” Further, most life sciences companies have yet to craft a legal or regulatory policy for Sidewiki usage. 

EyeonFDA has been assiduously monitoring life sciences company websites for the appearance of Sidewiki. To date EyeonFDA has found it on the following company websites:

1. Abbott
2. Amgen
3. AstraZeneca
4. Bayer
5. Baxter
6. Bristol-Myers Squibb
7. GSK
8. Johnson & Johnson
9. Lilly
10. Novartis
11. Novo Nordisk
12. Pfizer
13. Roche
14. Sanofi-Aventis
15. Takeda

While Google would like everyone to believe that Sidewiki is taking the Internet by storm and spreading like the H1N1 virus, a show of hands at yesterdays e-Patient Connections 2009 meeting in Philly, which was attended by many computer geeks and social media enthusiasts, revealed that about4 out of about 150 had heard of it! Nevertheless, it is out there and life sciences companies would be well advised to formulate internal legal and regulatory guidelines despite the fact that FDA hasn’t issued any guidance on its use.

P.S. Shortly after I posted this, @pharmaguy alerted me to an article that appeared on the today's online PharmaExec.com entitled "SideWiki: What's Pharma To Do"?

Until next time...

Good Luck and Good Commenting

• Email This
• Print
• Comments
• Trackbacks
• Share Link

e-Patients Connections 2009 (#epatcon) was held this past Monday and Tuesday at the Park Hyatt hotel in Philadelphia, PA. BioCrowd was one of several co-sponsors of the event. The theme of the conference, organized by Kevin Kruse a veteran medical communication and training expert, who now runs Kru Research, was to “reach, engage and educate empowered digital health consumers.” And, boy, did it deliver! While this was Kru Research’s first official conference, it was well organized, extremely interactive and the quality of the speakers was second to none! Topics that were featured included social media and the life sciences industry, technological advances in e-based healthcare delivery, the relationship between the news media and healthcare information and the continuing evolution of online and e-based healthcare communities.

Conference attendees included representatives from the life sciences industry, medical communications experts, advertising and marketing professionals and a multitude of social media enthusiasts and consultants who kept the Twitter screen humming throughout the meeting (a big shout out to the “troublemaking table”). And, surprisingly, there was a representative from the Division of Drug Marketing and Advertising and Communications (DDMAC) at the US Food and Drug Administration, who I believe, was one of the most sought after individuals at the meeting. CNN reporter Elizabeth Cohen who writes the Empowered Patient and racecar driver Charles Kimball, a type I diabetic and company spokesperson for Novo Nordisk also gave talks.

My favorite talks were those presented by online patient community organizers including Tricia Geoghegan of Ortho-McNeil-Janssen Pharmaceuticals who created the Facebook ADHD Allies community, Lisa Tate of WomenHeart and Robert Schumm of Bayer Consumer Care who created Facebook Strong@ Heart and Rachel Lewinson of the Juvenile Diabetes Research Organization and Susan Harrow Rago of Novo Nordisk who created Juvenation.org a website dedicated to those with Type I diabetes. These communities are outstanding examples of how partnerships between pharmaceutical companies and advocacy groups can help to better educate the public and heighten awareness about potentially life-altering diseases. Another example of a great online community and healthcare portal is Insomnia 123.com. This website was conceived and constructed by Christine Macadams and her partners’ one of whom is a practicing physician. Unlike the other online communities, which are sponsored and mainly supported by consumer healthcare division of large pharmaceutical companies, Insomnia 123.com was exclusively created by a group of concerned individuals who wanted to better educate and improve the lives of people with insomnia—a largely unreported and self-medicated condition.

On the technical side, the talks presented by Lee Segal of Klick, Kevin Durr of Avantera , Ian Kelly of Red Nucleus and Scott Ballenger of ListenLogic were illuminating and extremely informative. Some of the innovations taking place in digital media are exciting and almost overwhelming at times (even for a social media enthusiast like me). I think the company to watch is ListenLogic which uses semantic search engines to collect real time data and “chatter” on the web. This technology may provide a cost-effective solution to assuage the concerns of many life sciences companies that claim that collecting and analyzing overwhelming amounts of data is one of the main reasons why they are reluctant to entry the social media space.

Marc Monseau of Johnson and Johnson gave an illuminating talk on his experiences as a corporate blogger and Twitter user and described some of the challenges that had to be overcome before his company was able to break the “social media barrier.” Janice McCallum, an economist by training and a healthcare communications and media expert gave an informative talk about the growing role and impact of patient-generated healthcare content on patient awareness and education.

Finally, the novel and innovative Pecha Kucha sessions were outstanding and extremely well done! While all were expertly crafted, Dr. Val’s and Jonathan Richman’s Pecha Kucha were memorable. Dr. Val’s, which was extremely powerful and moving, was performed entirely in verse and Jonathan’s was—well, one of Jonathan’s always entertaining and informative presentations.

In summary, the “e-Patient Connections 2009” was a resounding success and in my opinion reached its goal to “reach engage and educate empowered digital health consumers.” That said, I can’t wait for “e-Patient Connections 2010” meeting!!!

Hat tip to @ellenhoenig and @eileenobrien for inviting me to my first tweetup (great fun) and finally meeting @janice McCallum, @christianeTrue, @stevewoodruff and Silja aka @whydotpharma! 

Until next time...

Good Luck and Good Job Hunting!!!!!!!

• Email This
• Print
• Comments
• Trackbacks
• Share Link

Whenever I do resume critiquing at scientific meetings, someone always asks about how to negotiate a job offer.  Most of the people that ask the question aren't even close to receiving a job offer and I do my best to deflect the question.  However, at a recent meeting, I spent 30 minutes with a PhD student who had received an offer advising him on how to get a better deal from his prospective new employer.  This got me thinking and I invited Joe Tringali, a veteran recruiter with lots of negotiating experience to write a blog post about strategies and things to consider when negotiating a job offer.

The "Dos" and "Don'ts" of Negotiating a Job Offer

by Joe Tringali

Invariably, the topic of salary negotiations in the interview process makes its way to the surface and, as a seasoned professional recruiter, I have a few thoughts that I would like to share with jobseekers.  During the course of my almost 30 year career, I have work as a traditional “headhunter” and also as on onsite contract recruiter for pharmaceutical and biotechnology companies, shifting gears and mindset as warranted by the particular client and the task at hand. In other words, I have been on both sides of the negotiating table either on behalf of a job candidate or a client company.

Fundamentally, job seekers need to understand the “economics” surrounding their search; who—the candidate or employer—has the most leverage in the relationship? Is there more demand than there is supply for a candidate with a specific set of skills or is there an excess of talent allowing an employer to choose the absolute best candidate for job. That said, consider the following:

A candidate who has received an offer can always try to negotiate to see how far they can push  the employer. As a rule of thumb, the initial offer that is proffered is usually not the best offer and if you aren’t satisfied with it, try and negotiate for a better deal.  If you ask and you don’t get what you want, the initial offer will likely still stand but you won’t have any regrets or say to yourself “I should have asked” if you eventually accept the offer. On the other hand, if the offer IS negotiable, it’s most likely only negotiable within a finite range. To that end, you must “come to the table” knowing your worth and what the compensation and benefits standards are for comparable positions in the industry. Rest assured that the prospective employer is at least as prepared as you are (usually more so) when it comes to negotiating offers. After all, most companies have dedicated compensation departments that spend a good portion of their workweek establishing fair compensation ranges. This doesn’t mean that you shouldn’t ask and attempt to negotiate, but simply that you must temper your expectations and not “expect the world.” Typically, employers are limited with what is negotiable in an offer. Things that are typically not negotiable are base salaries and healthcare and financial benefits. Other things like vacation time, sign on bonuses, relocation costs etc are. The reasons why base salary and benefits are not negotiable are because companies try to maintain internal equity among its employees.

When to negotiate? The obvious answer is to negotiate from a position of strength—when a formal offer has been extended (but never before). The offer signals that a company “wants you” and the candidate ought to consider the offer as it stands. Assuming the offer is fair (and the candidate SHOULD know his/her worth as part of the search process), accept it and move on with your career. Should you feel it isn’t quite up to par based on your understanding of your skills and marketplace demand, you might consider a conversation that sounds something like the following:

“I’m thrilled to receive the offer and am trying to find a way to make this work for both parties. My understanding of the market ( from online research, university career services, friends with similar experience, in similar roles, in similar geography,  is that an offer of 2k more might be more in line. IF there is any way you can bump the offer up by 2K, I will accept it and start on XXX date”

In other words, you are offering something back (acceptance/start date) in exchange for a possibly bump in the offer (most companies want you to start sooner rather than later). The worst case is that the employer comes back and says they cannot do any more with regard to compensation. Depending upon your assessment of the situation, you might then try to negotiate additional vacation days or an increase in relocation costs to offset the $2K that you need to feel comfortable to accept the offer. If the answer is still no, the original offer stands until you either accept or reject it—the decision is yours. Generally speaking, most offers are fair and in the range you might expect given your background and years of experience in the industry. But, only you can determine whether or not an offer is right for you. Ultimately, that decision ought to be based on compensation requirements, job responsibilities, geography, and whether or not an offer will meet your needs at this particular time in your life.

Until next time...

Good Luck and Good Job Hunting!!!!!

Joe Tringali is a Principal with Tringali & Associates, Inc., a recruitment consulting practice based in Manchester, New Hampshire. He has over 30 years of progressive experience in the field of Human Resources and is particularly well-qualified in the design and implementation of creative staffing programs and executive search practices within the Life Sciences. Some his clients include Pfizer, Eisai Pharmaceuticals, Millennium Pharmaceuticals, Biogen Idec, Genzyme , TKT/Shire , Harvard University and Infinity Pharmaceuticals.

• Email This
• Print
• Comments
• Trackbacks
• Share Link

An annual survey conducted by Science magazine and the American Association has identified the 2008 top twenty life sciences employers in the world. The rankings were based on a company’s leadership, stability, social responsibility and treatment of its employees. Six of the top 10— Genentech, Gilead Sciences, Genzyme Corp., Schering-Plough Corp., Gilead Sciences are based in the US whereas the remaining four—Boehringer Ingelheim, Roche Pharmaceuticals, EMD Serono, and Millennium are headquartered outside of the US. For the first time, eight of the top 20 are located outside the United States.

In case you were wondering, Genentech was ranked number 1. This is the fifth time out of the past 6 years that the San-Francisco based company made it to the number one slot (it fell to second last year). Another notable is Massachusetts-based Genzyme which made it to the number 3 spot (out of 575 companies) for the second consecutive year. Surprisingly, Monsanto, the company that makes genetically modified seed crops, was number 2—this despite all of the negative press about genetically modified foods. Let see whether or not Genentech can retain its number 1 ranking after the Roche takeover of the company is completed.

Until next time....

Good Luck and Good Job Hunting!!!!!!!

• Email This
• Print
• Comments
• Trackbacks
• Share Link

In a previous post I lauded health information technology (HIT) aka health informatics as a possible new career choice for scientists with life sciences PhD degrees who also have a proclivity for software development and data base management. Shortly after I posted the piece, I happened to read an article in a local publication about a NJ-based company called the MISI Company that is at the forefront of the HIT field and developing software to help digitize American healthcare records. 

I invited Dave Roth, an MISI executive, to share his views on the future of HIT and what ought to be done to insure that e-medical records are appropriately and successfully created. BTW, for my bioinformatics and genomics friends, MISI is looking to hire a few talented men and women who are interested in HIT careers.

HIT: The Other Missing Link

by Dave Roth

Health information technology (HIT) is hot. There’s every reason to believe that HIT will play a major role in the reforms envisioned for our health care system. From President Obama announcing $5B in grants to aid medical research, to bioinformaticists developing tools for predicting genetic predisposition to diseases, to software developers working on electronic medical records (EMR) systems, HIT is a burgeoning field. What concerns people like me – read: people who are users of technology rather than the developers of it – is that all this HIT talk seems to have very little mention of us in it.

Not long ago, I wrote an article called The Missing Link in Healthcare IT: The Consumer. In it I pointed out that none of the current government definitions being proposed for "meaningful use" of electronic medical record (EMR) systems define meaningful from the healthcare consumer's perspective. I also noted that whatever rules the government establishes for receiving stimulus money for the development of HIT solutions, none of them will exclude technologists from collaborating with consumers in the development of their solutions. I posited that technologists would be doing us all a favor if they would stop to consider for a moment how their systems will affect the consumer’s experience of health care services.

I was encouraged when David Goldhill, in his cover story in the September 2009 issue of Atlantic Monthly, How American Health Care Killed My Father, wrote, “[A] guiding principle of any reform should be to put the consumer, not the insurer or the government, at the center of the system.” Goldhill’s prescription for a better health care system begins with advocating for the consumers of services and focusing on how to get the best outcomes for those consumers at a reasonable cost. He was channeling the views of many people, such as Harvard Business School professor Regina Herzlinger, who believe consumer-driven health care is the only reform that will truly be meaningful.

The growing visibility of the consumer in this debate has gotten me to thinking there is real opportunity in the HIT job market for another missing link: Consumer-centric Health IT Developers. It is a rare developer who brings to his/her craft an appreciation of the importance of understanding who you are developing for. Rarer still is the developer who is aware of and employs tools and techniques for capturing end-users’ feedback during the development process. More often than not, user-centered design (UCD) is considered a luxury that burns up time and precious dollars. This misconception is largely the result of development teams typically waiting until they are too far into the development cycle before engaging with those who will be using their creation. Inevitably, problems are discovered with the usability or utility of the system that will hinder adoption. But the problems are discovered too late to be fixed by the target launch date and/or within budget. Users/Consumers become the enemy in this scenario.

There is another way. HIT technologists should understand how and why to engage their target audience at the beginning of the development process, long before anything is actually developed. They should begin by understanding who they are developing for, what these people are looking to accomplish, and how they can best help them accomplish it. Using such techniques has been shown to actually reduce downstream development work and increase adoption. I believe technologists schooled in the techniques of consumer-centered design will be central to any successful, long-term health care reform.

Dave is Vice President and  heads MISI Company's Experience Design (XD) group - a group of strategists, experience architects, visual designers and technologists whose mission is to help ensure the success of every interaction between a business and its target audience. His career spans 30 years and includes award-winning work in documentary and corporate film/video, print advertising, and interactive software application development for computers and the Internet. Dave is a Stanford University grad, a SF 49ers fan and a member of the Single Malt Scotch Whiskey Society.

• Email This
• Print
• Comments (1)
• Trackbacks
• Share Link

While pharmaceutical and biotechnology companies have been reluctant to use social media, Bio-Rad, Applied BioSystems and other life sciences reagent and instrumentation companies have jumped on the YouTube video train with reckless abandon.

A quick perusal of the molecular biology-related videos on YouTube reveals several scintillating titles like “Do the Double Helix,” “DNA Replication Rap,” and my personal favorite from Bio-Rad, “The PCR Song” (see video below)

Until next time....

Good Luck and Good Watching !!!! 

• Email This
• Print
• Comments
• Trackbacks
• Share Link

NextLevel Pharma has organized several life sciences meetings that may be of interest to BioJobBlog readers. These include: a webinar entitled “Safety Biomarkers in Drug Development” on October 14 and 21, 2009; a conference, “Best Practices in Phase IV Clinical and Observational Research” December 3-4, 2009 in Prague, Czech Republic and “Advancing Biologics from the Lab to the Clinic", January 11-12, 2010 in Brussels, Belgium.

Each of these offerings offers ideas and insights into important issues that are emerging in the life sciences industry. Check it out!

Until next time....

Good Luck and Good Job Hunting!!!!!!!

• Email This
• Print
• Comments
• Trackbacks
• Share Link

Have you ever received a call from a “head hunter” who suggests that they might be able to assist you in your job search? Can professional recruiters actually help you find a job? Finally, have you ever wondered what’s in it for the recruiter if they don’t charge jobseekers a fee to help them with their job searches?

If you are curious about these and other questions, please listen to a podcast  of BioCrowd founder Cliff Mintz's interview with Romi Kher, the host of Cornell University’s 10GoodMinutes ,a talk show that provides career advice for young professionals.

Until next time...

Good Luck and Good Job Hunting!!!

• Email This
• Print
• Comments
• Trackbacks
• Share Link

I previously posted an article on BioJobBlog about biomedical and scientific search engines. One of them called Novoseek, which is mainly geared for life scientists, has recently launched a new set of features known as  My Novoseek

My Novoseek allows users to create a personal account to store and manage indiviudal Novoseek searches. Its functionalities include:

• Search history
• Saved searches
• Search labeling and indexing
• New publication alerts
• Account filtering and management

These newly introduced features improve Novoseek’s search capabilities, content management and convenience. For example, saving searches and creating alerts offers users a facile and convenient way to be alerted when new papers are published in your areas of interest. Also, Novoseek’s indexing and content management features makes creating and labeling collections of papers really easy. Finally, the ability to customize and manage account settings and view search histories makes searching for new information easier, less time consuming and prevents search redundancy.

While I haven’t spent much time evaluating other biomedical search engines, my experience with Novoseek has positive and I recommend that you check it out. Also, unlike other biomedical search engines, Novoseek has a distinctive social media bent and is using it to constantly add new features to meet new and exisitng user demands. To that end, Novoseek maintains its own blog to keep user abreast of happenings in the biomedical search engine world and can be found on Facebook and Twitter.

Signing up for Novoseek is easy, requires only three steps and only takes five minutes or less.

Please visit the Novoseek website and let me know what you think.

Until next time...

Good Luck and Good Searching!!!!!

• Email This
• Print
• Comments
• Trackbacks
• Share Link

Eli Lilly & Co announced today that it is eliminating another 5,500 jobs or roughly 14% of its global workforce over the next two years. This would reduce to size of Lilly’s worldwide workforce from 40,500 to 35,000 by 2011. In addition to the job cuts, the company is reorganizing itself into 5 business units and hopes to save about $1.0 billion in annual costs.

These newly announced job cuts come after the company eliminated 4,000 sales representative jobs this past August and restructured its sale force. Also, prior to the recent cuts, Lilly launched the Lilly Phenotypic Drug Discovery Initiative or PD² a new program to ostensibly strengthen relationships with academic institutions to speed drug discovery and thereby reduce its reliance on internal drug discovery efforts to keep its pipeline full.

Unlike other major pharmaceutical companies that conducted massive layoffs over the past two years, Lilly was content, until the past few months, to lay off small numbers of employees and offer others retirement packages. Unfortunately, the loss of patent protection on several of its blockbuster drugs coupled with generic encroachment on several brands and impending health care reform, forced Lilly to take more draconian action.

Layoffs have been something of rarity in the life sciences sector over the past eight months or so, but this is usually the time that marks the beginning of the corporate “layoff season.” Don’t be surprised if other large life sciences companies announce similar layoffs in the coming months. Luckily, the economy seems to be improving and there are signs that hiring is beginning to ramp up in the pharmaceutical, biotechnology and devices industries.

Speaking of pink slips, those of you who have been downsized or find yourself out of a life sciences job may be interested in a new organization called Pink Slip mixers. According to a description on the group’s website:

“Our Pink Slip Mixers are about hundreds of professional, mid- to upper-level executives who are (might be) victims of the "economic downturn" of 2008. Our parties are about banding together, networking and bonding with the recently "Pinked". We will share our experiences of why we were let off, what companies are hiring, and the "buzz words" that specific hiring managers want to hear. Aside from the usual imbibing, commiseration and fun that every pink slip party brings, headhunters, direct-hire companies, and recruiting firms will also on-hand to learn a little bit more about what you do. Maybe you'll meet a new contact, or find a new job!” 

Sounds like these mixers might be good networking opportunities and a place to kick back and commiserate with others who are no longer gainfully employed. I am planning to attend a Pink Slip Mixer when one is organized in the NYC metropolitan area. Like many of you, I lost my full time contract copywriting job over a year ago!

Until next time...

Good Luck and Good Job Hunting!!!!

• Email This
• Print
• Comments
• Trackbacks
• Share Link

Twitter is arguably the hottest new platform to hit the social media scene is the past five  years. Twitter devotees are convinced that anything is possible if the microblogging platform is used correctly. In today’s economy, the most pressing need for many people is finding a job. While Twitter is effective for branding, marketing and occasionally some witty intellectual exchanges, its usefulness for jobseekers has yet to be demonstrated. To that end, there was a recent instructional case study on TwiTip—“5 Methods I Used To Get a Job Through Twitter”— that describes how Twitter can be used to find gainful employment. Although the case study focuses on non-science jobseekers, many of the suggestions and recommendations are relevant to those seeking jobs in the life sciences.

Read and learn!!!

Until next time...

Good Luck and Good Job Hunting!!!!!!

• Email This
• Print
• Comments
• Trackbacks
• Share Link

Lisa Roner, blogger and editor for EyeforPharma, recommends a podcast on social media that was created by Dr. Andree Bates, CEO at Eularis, a company that applies analytics to determine the sales impact of specific marketing programs.

Dr. Bates says it is an important area for pharmas to become engaged in social media.  In the podcast, she offers some ideas about how pharma marketers might apply these channels effectively. Also, she offers some tips and hints for intrepid pharma employees who are interested in getting started.

To listen to the podcast click here.

Until next time...

Good Luck and Good Networking!!!!!!!!

• Email This
• Print
• Comments
• Trackbacks
• Share Link

During my recent trip to Vermont and Woodstock, NY I had several conversations about Twitter. Surprisingly, I was being asked to explain Twitter to my nephews, both of whom are in their early 20s and to family friends who are in their late 40s and beyond. Also, at several recent science career fairs that I attended many graduate students and postdocs had never heard of Twitter or it they had, they don’t use it. Initially, this was puzzling but after considering the most recent Twitterverse demographics –I think the average age of Twitter users is around 35 to 40—it made more sense to me.

Anyhow, I have found that it is time consuming to explain Twitter to people who have heard about it but don’t quite understand how it works. To that end, several people— who I follow on Twitter— (@ LaurieDesAutels and @Recruiting Animal) tweeted about an article by John C. Dvorak that offers an excellent review of Twitter and several practical ways to use it.

I hope that the article provides some insights into Twitter and how scientists might be able to harness its incredible power and reach. You can follow me on Twitter @biojobblog!

Until next time...

Good Luck and Good Tweeting!!!

• Email This
• Print
• Comments
• Trackbacks
• Share Link

Like it or not, writing a carefully-constructed resume or curriculum vitae (as resumes are known in scientific circles) is a vital part of any successful job search. Inexperienced job seekers tend to hastily craft resumes without paying much attention to format, style or content and then wonder why they can’t land job interviews. The best way to approach resume writing is to think of a resume as a work of art–something that requires a lot of thought, creativity and attention to detail. As one well-known professional recruiter and job search expert put it”Trying to find a job without a smart, well-crafted resume is like showing up for dinner at a fancy restaurant in a T-shirt and cutoffs. They won’t let you in.” 

I think that it is important for job seekers to think of a resume as a personal marketing brochure that will either land a job candidate interviews or turn a job search into a long, arduous and frustrating process.

The primary goal of a resume is to show prospective employers how you are different than other applicants and why you and not they ought to get the job! So, what are the salient features of a winning resume?

Writing tips

Hiring managers, professional recruiters and human resource professionals tend to quickly scan resumes that they receive and make snap judgments. Therefore, your qualifications and personal attributes must “jump off the paper.” This can easily be accomplished by using bold type, headings, underlining, bulleting and varying font sizes–all of which are simple ways to visually call attention to your strengths. Avoid using paragraphs because they are dense and difficult for hiring managers to navigate.

Powerful, action-oriented, emotional words produce a strong, positive impression. Unfortunately, we scientists have been trained to write in the “passive voice.” That said; try to resist using the passive voice as much as possible when crafting your resume–think outside the box!

Job Objective or Summary Statement

I am sure that somebody has told you at one time or another to include an “objective” on your resume. Objectives tend to be boring, vague and passively delivered. Instead, I highly recommend that you craft a vibrant, action-oriented, can-do “Summary of Qualifications” that accurately reflects and highlights why you are a “right fit” candidate for the job. To that end, it may be necessary to craft more than one summary of qualifications if you are applying for several different types of jobs. For example, your summary statement for an R&D job should be markedly different than the one that you would use to land a business development job.

Which of the following examples do you think better positions the job candidate?

Objective: To obtain a research scientist position at a pharmaceutical company

Or

Summary of Qualifications: Experienced scientist with expertise in protein purification and microarray technology. Exceptional leadership abilities and outstanding oral and written communication skills. Able to work independently or as part of a multidisciplinary team.

Professional Experience

Resumes can be constructed either chronologically or functionally. Chronological resumes, which are most common, list content in temporal order and should be used for either lateral job moves or when seeking a promotion or looking for a new job to advance your career. When crafting a chronological resume, jobs or work experience must be listed from most recent to past. In contrast, functional resumes offer content based on skills and are most effective for individuals who are seeking career changes. Functional resumes should present your skills in the order of importance for the new career that you are pursuing. 

It is important to stress that only information relevant to the position should be included in a resume. Unrelated job titles or skills can sometimes confuse hiring managers and may cause them to pass on a qualified candidate. As mentioned above, most hiring managers and employers are simply too busy to read all of the resumes that they receive. Resumes that are chosen for further considerations are typically the ones that contain pertinent, job-specific information that is presented in a straightforward and unambiguous manner.

If you switch jobs frequently or have gaps in your experience put the dates of employment in the far right hand column of the resume (we read from left to right so sometimes dates of employment are overlooked) or hide the job-changing by combining or grouping several jobs together to appear as one. Also, employment dates ought to be listed as years; not the exact start and stop dates of employment, e.g., dates should appear as 2001-2002 not July 10, 2001-January 15, 2002.

Tailoring Your Resume

A resume is not just a list of what you have done and where you have been. It is your opportunity to present and highlight the skills that you possess and how those skills translate into making you the right-fit candidate for a particular job. Quantifying or embellishing achievements and using strong, definitive statements elevate and add authenticity to you as a job candidate.

Which of these examples sounds better?

Designed and directed experiments to study Alzheimer’s disease

                                                            Or

Designed and carried out experiments that identified a key protein in amyloid plaque formation

For each position that you apply, it is critically important to list all relevant experience in the order of perceived importance to the hiring manager or employer. Carefully reviewing job descriptions will allow you to quickly and easily identify those things that are most important to the employer. What is seen first means the most! 

When necessary resumes should be tailored so that as many of your skill sets and accomplishments match what was stated in the job description. This means, that it is highly unlikely that you will be able to use the same resume/CV for all of the jobs that you are interested in. To insure success, I highly recommend that you take the time to customize or tailor each resume/CV that you submit to prospective employers.  When I was looking for a new job several years ago, I crafted no fewer than 20 different resumes!

Odds n Ends

Many of you may have heard that resumes should be no longer than one or two pages in length. While this may be the convention for other fields, it is certainly not applicable to CVs or scientific resumes. That said, it is a good idea to limit the length of your CV/resume because, outside of academic circles, nobody has the time nor the inclination to read a CV that is half an inch thick! When I was working as a professional recruiter, it typically took me a minute or less after scanning a resume/CV to determine whether I had identified a “right-fit” candidate. Candidates whose CVs are too long, overly verbose or difficult to decipher rarely make it to the interview stage. I subscribe to the notion that less is more and simple is elegant!

When listing your educational background, I recommend that present your lowest degree first (associate or bachelor) and end with your most advanced degree or educational experience, e.g. postdoctoral fellowships or professional school. The name and location of the institution that awarded the degree and your major or area of expertise should be listed with each. It is perfectly reasonable to list the names of your graduate or postdoctoral advisor in this section (if you think that a mention will help your candidacy). You may also want to include your thesis title if you wrote a masters or PhD thesis. It is not necessary to list the dates that the degree was awarded. By listing the dates that you received your undergraduate and graduate degrees, an employer may be able to deduce your age. While this may not be a bad thing for entry level employees, it may hinder more experienced job seekers from securing new positions.

Membership in professional societies, organizations or clubs should be listed in a section that is separate from your educational background. Any invited lectures or presentations may also be listed under a separate heading. Also, it is important to list any extracurricular activities or specialized skill sets that you think may be relevant to the positions that for which you are applying. For example, letting prospective employers know that you were an Olympic swimmer or president of the debate team may be what differentiates you from other equally-qualified job candidates.

All of your publications should be listed on the last page of your CV in a section entitled Publications.  If you are just starting your career, it is permissible to list along with your peer reviewed publications all of your abstracts, poster presentations, etc. However, if you are mid-career professional, I strongly recommend that you list only peer-reviewed publications, review articles, books and book chapters and eschew the abstracts. Any manuscripts that are “in press” should be listed. That said,  I don’t think that it is appropriate to include “submitted” manuscripts –this signals to prospective employers that you may not think that your publication list is long enough to warrant consideration.

Never send your references to prospective employers unless they specifically ask for them. Simply indicate somewhere on your resume/CV that references are available upon request. For most academic jobs, it is customary to ask for references at the beginning of the application process. For industrial jobs, references are not requested unless an employer is interested in moving forward with specific job candidates.

Finally, it is vital that you understand that your resume is a required first step in the job search process. A carefully crafted resume/CV that indicates to prospective employers that you are the right woman/man for the job will likely get you to the interview stage. After that…it is all up to you.   Look for the next installment of the series on interviewing skills and tips.

Click here to see the wrong way to write a resume and here for an example of one that resulted in a job offer.

Until next time….

Good Luck and Good Job Hunting!!!!!!!!!!!!!

• Email This
• Print
• Comments
• Trackbacks
• Share Link

While many of you may not know this, background checks are routinely run on prospective new employees at most companies and organizatons before job offers are extended. Like it or not background checks are increasingly being run on scientists because of the US anthrax incident that occurred soon after September 11, 2001. I want to emphasize that background checks on being run on ALL employees (not only scientists) before being hired.

Guest blogger, Anne Stephanie Cruz of Crimcheck.com contacted me and offered to enlighten us about how background checks are conducted and the type of information that employers are seeking. Crimcheck.com provides background checks for businesses large and small nationwide. Crimcheck.com background checks include criminal history, education verification, employment verification, driving records and more.

The Expansion of Background Checks for Scientists

A series of events and the development of technology have changed the climate for employers wishing to do a background check on job candidates. With the heightened security requirements resulting from the threat of terrorism, background checks have become essential for many jobs in science. Many companies developed tight security including background checks years ago. For example, anyone entering a large chemical plant understands from the gates and security checks at each entrance that access to the facility has been tightly guarded for years. However, with the escalation of terrorism coupled with the ease of gathering information on a job candidate, even the smallest organizations are taking the opportunity to thoroughly check out their scientists before hiring them.

There has been much debate over this issue as long established procedures give way to tighter security measures. For example, after the contamination of letters with anthrax, some laboratories began to implement new security requirements for employees, including background checks of personal information as well as fingerprinting.

There are firm guidelines in the general population regarding the information that can be collected legally for an employment background check. Also, some information can be collected but not used to make a decision regarding employing a candidate, such as public bankruptcy information. However, federal rules have opened scientists up to closer scrutiny and allowed background checks to include more information.

Generally, the following information may be acquired during a background check:

The following are examples of information that cannot be included in a general employment background check:

1. Records of Arrest
2. Civil Court Records (after 7 years)

The use of information like bankruptcy, marital status, number of children, race, age, sex, religion, birth place, sexual orientation, living arrangements, or health is illegal in the hiring process for most professions. However, new rules have allowed scientists to be checked beyond these restrictions. For example, one rule had restricted citizens of countries suspected of supporting terrorism from working with certain dangerous biological agents.

Scientists were also restricted from some jobs based on a history of mental illness, felony convictions, or drug use. The sudden implementation of background checks and heightened security was particularly disturbing for many seasoned scientists who had been trusted employees for years. Privacy rights have been thrown aside in many cases, leading to a disturbance in the scientific community. Many lawsuits have sprung up as scientists scramble to protect their rights in this environment. Examples of organizations with widely known lawsuits over background checks include JPL and NASA.

The legal framework regarding background checks for scientists is constantly shifting. Scientists need to know that they are likely to be checked out thoroughly, not only when applying for a job, but throughout their career. Employers doing background checks should seriously consider hiring a reputable company to perform these checks in order to stay within the boundaries of privacy laws.

Until next time....

Good Luck and Good Job Hunting

• Email This
• Print
• Comments (3)
• Trackbacks
• Share Link

Despite dire predictions, the biotechnology industry appears to be weathering the recession better than most. According to a CNN Money.com post “Biotechnology leapt ahead as the biggest recipient of U.S. venture capital money in the second quarter, but first-time venture investments in companies overall dropped to a 15-year low.”

Biotechnology funding grew 54% to $888 million in 85 deals, software came in flat at $644 million in 135 deals and Internet companies fell 15% to $524 million in 124 deals. While biotechnology company investments are leading the pack, the current funding levels pale in comparison to those of the late 1990s and early 2000s. Also, it is important to note that many of the biotechnology company investments were in mid to late stage ventures. Fewer investments were made in seed or early stage companies which historically have outpaced funding in late stage ones.

Venture capitalists may be favoring biotechnology investments because there is a clear exit strategy—there are more acquisitions and initial public offerings in life sciences as compared with other industries.

Look for continuing investments in the biotechnology sector—especially in molecular diagnostics and medical devices.

Until next time...

Good Luck and Good Job Hunting!!!!!!

• Email This
• Print
• Comments (1)
• Trackbacks
• Share Link

The “Social Media and Healthcare” conference that will be held on July 23, 2009 in NYC at the Graduate Center of The City University of NY (365 Fifth Avenue at 34th Street) is shaping up to be a great one. At present, over 350 people have registered for the meeting. There are a few slots left if you are interested in attending.

Several BioJobBlog readers have asked whether or not the sessions will be recorder and available online. Steve Etzler, one of the conference organizers told me that Blogtalkradio.com will broadcast and archive the audio from all of the case studies that will be presented during the morning sessions. Unfortunately, the round table discussions won’t be available.

As I may have mentioned, Cliff Mintz, Co-Founder of BioCrowd will be leading a roundtable discussion entitled “Building Social Networking Sites for Bioprofessionals.”

See you on Thursday!!!

Until next time....

• Email This
• Print
• Comments (1)
• Trackbacks
• Share Link

Back in the late 1990s, applying for jobs online was all the rage! The technology was new and fresh and applying for jobs online was fast and easy. Companies raced to build corporate websites for prospective job applicants, major job boards like Monster and Careerbuilder were launched and human resources professionals though they were ushering in a “new era of employee recruitment and retention.” While applying for jobs online once seemed like a panacea for both job seekers and corporate employers, it never has lived up to all the fanfare and hype!

There is no question that applying for jobs online is quick, easy and most importantly emotionally gratifying. Paradoxically, these are the very qualities that have almost rendered the practice useless when it comes to finding a new job. Before applying for jobs online became de rigueur, large numbers of qualified, prospective employees were hired into new jobs. Unfortunately, these days’ most corporate websites and job boards are swamped by unqualified applicants who submit their resumes when ever and where ever they can! This has prompted many companies and job board site to automate their applicant screening processes—which, in many cases, fail to discriminate between qualified and unqualified job applicants. Frequently, because of the sheer volume of applicants, many companies no longer acknowledge receipt of job applications. While this practice is unprofessional in my opinion, it sends a subliminal—if not obvious message—to applicants that the likelihood of winning the job is remote. It is not uncommon for job applicants to never hear from a company after they have hit the send button to submit a job application.

So, if applying for jobs online isn’t the answer, what should jobseekers do to find gainful employment? Like it or not, the best way to find a new job is through networking. The advent of social networking sites like Facebook, Linked In and BioCrowd makes networking less daunting than it used to be. However, it is important to note, that online networking alone won’t be sufficient! Unfortunately, (for some of you anyway), interacting with people in real life will be required! The best way to begin networking is to use Google (or your favorite search engine) to identify companies or institutions that are looking for applicants with your skills and qualifications. Next, work hard to find a contact at a company who is willing to support your application or at least, forward it to an appropriate hiring manager. If you don’t know anybody at the company ask friends or relatives if they do. If this doesn’t work, post a notice on Facebook or Linked In asking if anybody in your network can provide a contact name or phone number of a hiring manager at the company you are interested in. If this also proves to be unsuccessful, you can run at Internet search on a particular advertised position or go to a company website to find the name of a hiring manager. However, to avert an avalanche of inquiries about online job postings, many companies no longer list the names of hiring managers on their websites. If all else fails, you can always put in a call into human resources and ask for more information about a job with the hope of getting the hiring manager’s name.

Once you obtain the name of a hiring manager, send an e-mail message indicating your interesting the position along with an attached resume/curriculum vitae. One note of caution; managers are usually inundated with e-mail messages (many which remain unanswered) and often have their spam filters set on high. Consequently, it may be prudent to also send a hiring manager an old fashioned cover letter and curriculum vitae authority using traditional or overnight mail delivery.

While networking to get an employee referral for a job remains the best way to get your “foot-in-the-door” at most companies, the referral channels, like almost all others, are also extremely clogged. This may require a direct phone call to a hiring manager to inquire about whether or not to apply for a job or to check on the progress of an application. That said, use this approach wisely—some managers may think that this shows initiative (and will pull your resume from the resume heap) while others may be offended or annoyed by your boldness. Nevertheless, once you make the call, DO NOT call back unless you are advised to do so. If the company is interested in you as a job candidate, they will contact you after they have had sufficient time to review your application.

While companies continue to advertise positions, the best way to land a new job is through word of mouth. This is because many companies don’t advertise all open positions and some companies run ads even though they are not hiring. Nevertheless, building a solid network of contacts and friends (both online and in real life) is critical for successful job searches.

In today’s difficult economy it may be prudent to employ a multifaceted job search strategy that includes a mix of networking, job boards and online applications. Also, it is important to cast as wide a job net as possible and not limit your search to a specific job type—especially if you have skills  and qualifications that cut across disciplines. Finally, I always tell prospective job candidates that looking for a new job must be a “full time endeavor.” Devoting less than a full time effort to your job search will likely yield disappointing results!

Until next time….

Good Luck and Good Job Hunting!!!!!!!!

• Email This
• Print
• Comments (1)
• Trackbacks
• Share Link

Despite its humble beginnings in the late 1970s, the biotechnology industry has transformed itself into one of the most vibrant sectors of the American economy. Pharmaceutical companies, once the bell weather of the life sciences industry, have finally conceded that biotechnology and not small molecules are the industry’s future!

While growth of the biotechnology industry has slowed somewhat in the past couple of years—mainly because of the recession—it still represents a viable career option for students interested in the biological sciences. Contrary to popular belief, a PhD degree is no longer required to gain employment in the biotechnology industry. The PhD degree option is slowly being replaced by biotechnology masters and undergraduate degrees and certificate programs readily available at many two year colleges. Put simply, there is a decreasing demand for PhDs at many life sciences companies—mostly because of technological advances and a growing reliance on outsourcing to carry out drug discovery and development. However, the demand for non-PhD employees with solid biotechnology backgrounds particularly in the areas of regulatory affairs, licensing, business development, medical communications, health informatics and biomanufacturing is rising.

For many students (especially high school and undergraduates), the plethora of biotechnology degree and certificate programs can be overwhelming. With this in mind, I came across a cool website called Biotechnology Degree Guide which helps students decide which program is right for them. The site is run by Webster Jorgensen who sent me the following information about the site.

“Biotechnology Degree Guide was developed to be a complete and comprehensive guide for finding colleges, universities and technical schools offering biotech and related programs. The site also features a rating system that allows registered users to rate various biotechnology programs. This feature was added to help separate the great programs from the not-sop-great ones. In the future, we plan to start highlighting "Hidden Gem" programs section that helps schools with lower profiles and great programs receive more exposure. The sites members section is open to prospective students, students, professionals, teachers and biotech hobbyists.  A social media component is planned for the future.”

While the Biotechnology Degree Guide may not answer all of your questions, it certainly is a good place to start when considering a career in biotechnology!

Until next time...

Good Luck and Good Job Hunting!!!!!!!!!!

• Email This
• Print
• Comments (1)
• Trackbacks
• Share Link

The economic crisis is having an adverse effect on enrollment at four year colleges and universities. Most four year institutions are reporting record low enrollments. While things are spiraling downward at many four year colleges and universities, business is booming at two year technical schools and community colleges. Seemingly, this ought to be good news for two year institutions. Unfortunately, statewide funding cuts and faculty shortages are making it difficult for community colleges and technical schools to accommodate burgeoning enrollment.

The rising enrollment at community colleges can almost exclusively be attributed to the current cost of attending 4 year colleges and universities. The cost differential between attending four year institutions and community college is stunning. For example, tuition at Miami Dade Community College, the largest community college in the US, is $1,000 per semester for Florida residents. In marked contrast, tuition at the University of Florida—a public institution— is roughly $5,000 per year and a whopping $42,000 at the University of Miami which is private.

Undergraduates are flocking to community colleges simply because many can’t afford to pay tuition for 4 or more years at most colleges and universities. The new paradigm for undergraduate education is to complete the first two years of college at a community college and then transfer to a 4 year college to finish a degree. Unlike other post secondary education institutions, there are no entry requirements at community colleges—open enrollment is the norm. This means that these schools are obliged to allow anybody with a high school diploma or GED to register for classes. In marked contrast, four year colleges and universities can regulate the size of their incoming freshman classes to deal with financial difficulties. For example, because of budget cuts in Florida, the state's 11 public universities have imposed caps on freshman enrollment. This has put increasing pressure on community colleges in Florida and other stacks to “pick up the enrollment slack.”

While attending community college may be an economical way for students to earn undergraduate degrees, two year colleges have been overwhelmed by the massive enrollment increases. "As it stands right now, we have almost 39,000 students registered for the fall term, and we began fall registration only two weeks ago," says Dulce Beltran, registrar at Miami Dade College. "And a quarter of the courses are already closed with almost two months to go before fall term begins." Not surprisingly, Miami Dade officials say that enrollment is 60 per cent higher than last year’s pace. School officials have been hiring new instructors and adding new courses to handle the enrollment surge.

Unfortunately, school officials estimate that 20,000 to 30,000 students won't get all the classes they need; 5,000 may not be able to sign up for any classes in the fall. Similar scenarios are playing out in other states including Arizona, California, Washington and others. Officials in those states are fearful that hundreds of thousands of prospective new students will be turned away this year.

There is no question that the recession is taking a toll on the ability of American students to attend college. However, the cost of an undergraduate education has been steadily increasing for the past decade. Rising overhead costs, higher faculty salaries and over expansion have all contributed to the increases. Something will have to give soon. Don’t be surprised if the education bubble is the next one to burst!

Hat tip to NPR!

Until next time....

Good Luck and Good Learning!!!!!!!

• Email This
• Print
• Comments
• Trackbacks
• Share Link

Over the past few years, a number of search engines designed for the life sciences have appeared. I thought it might be informative for BioJobBlog readers to list some of the more popular ones and how they are used. I want to warn you in advance that this is not a comprehensive list. That said, if I’ve inadvertently omitted your favorite search engine, please feel free contact me or simply list it in the comments section for this post.

Scirus

Searches over 450 million scientific items, and allows researchers to search for not only journal content but also scientists’ homepages, courseware, pre-print server material, patents and institutional repository and website information. This site is owned and managed by Elsevier.

Novoseek

Search engine for biomedical literature in medline, grants and full text publications that will help you to: 1) retrieve meaningful documents related to your search, 2) narrow your search to find results in the relevant scientific journals and 3) identify the most relevant biomedical concepts for your query.

Mednar

Mednar is a free, publicly available medical research run by Deep Web Technologies.

Valdo 

A search engine that caters to all branches of life sciences. VADLO allows users to search within five categories: Protocols, Online Tools, Seminars, Databases and Software.

Life Sciences Search Engine

A customized search engine developed for the benefit of researchers in life science.

ScienceHack

BioPages

Australian web portal and life sciences search engine.

Science Bucket

Specialized search engine that filters biology sites.

GoPubMed

Knowledge-based search engine for biomedical texts. It allows users to identify experts in the biomedical field.

Until next time...

Good Luck and Good Searching!!!!!!!!

• Email This
• Print
• Comments (3)
• Trackbacks
• Share Link

Back in the day—when the economy was sound and jobs were plentiful—an adequately written resume with a sprinkling of keywords and strategically-placed human resources clichés were sufficient to get your foot in the door at most companies. However, in today’s troubled economy where unemployment is rampant, there are certain buzz words and phrases that no longer resonate with hiring managers. According to Liz Ryan, an experienced  corporate career advisor who writes for Yahoo Hot Jobs, the following phrases must never appear in a resume if you are a job seeker in today’s market. 

• Results-oriented professional
• Cross-functional teams
• More than [x] years of progressively responsible experience
• Superior (or excellent) communication skills
• Strong work ethic
• Met or exceeded expectations
• Proven track record of success
• Works well with all levels of staff
• Team player
• Bottom-line orientation

She contends (and rightfully so) if old and tired phrases (like the ones mentioned above) appear in you resume you run the risk of being marked as “uncreative and vocabulary challenged.” Further Ms. Ryan suggests that you “can make your resume more compelling and human-sounding by rooting out and replacing the boring corporate-speak phrases that litter it, and replacing them with human language— things that people like you or I would actually say.” 

This language change is being driven by the informal nature of social media and a growing emphasis on truthfulness and transparency in the business. Nevertheless, well written resumes—with or without buzz words or key phrases—have always been and remain the first step in the sometimes long and tedius process of landing a new job!

Until next time...

Good Luck and Good Job Hunting!!!!!!!

• Email This
• Print
• Comments
• Trackbacks
• Share Link

Amber Johnson at Job Profiles suggested that BioJobBlog readers might be interested in this post about Twitter and job searches. While I can’t personally speak to the utility of using Twitter as a job search tool, it certainly can’t hurt to give it a try in today’s challenging economy. 

100 Useful Twitter Tools and Feeds for Your Job Search

If you're searching for a job, surely you've learned about the extensive amount of tools available online to help you land your perfect position. But did you know that Twitter is the hottest job search tool out there today? It's true -- employers, recruiters, and job search sites are flocking to the service. Check out this list to find tools and feeds on Twitter that can be a great help to your job search.

Search

Use these tools to search for the jobs being posted on Twitter.

1. TwitterJobSearch: With TwitterJobSearch, you'll be able to find tweets about jobs posted on Twitter.
2. TwitterTroll: TwitterTroll is a really useful real-time Twitter search engine.
3. Twitter Job Finder: Find fresh jobs on Twitter from the last 7 days on Twitter Job Finder.
4. Tweet Scan: Perform searches and register for email alerts using Tweet Scan.
5. TwitterJobCast: TwitterJobCasts' local job search will help you see who is hiring on Twitter in your area.
6. NearByTweets: You can search Twitter by keyword and location with NearByTweets.
7. TwitHire: This Twitter-based job board broadcasts a variety of listings.
8. JobMotel: Search for Twitter web developer jobs on this site.

Connections

With these tools, you'll be able to find and manage connections with others on Twitter.

9. TwitterMind: With TwitterMind, you can seek out Twitter users from the companies you'd like to work for and ask them for referrals.
10. Twellow: Use Twellow to identify the leaders you should connect with in your industry or community.
11. Workhound: Find a directory of the best Twitter job feeds on Workhound.
12. Just Tweet It: Find other Twitter users with similar interests on Just Tweet It.
13. TwitDir: Find some of the top Twitter users in this Twitter directory.
14. Twubble: Twubble will help you find more people to follow, reflecting on who your followers are following.
15. Twollo: With Twollo, you'll be able to automatically follow users with similar interests to yours.
16. FriendOrFollow: Find people you need to ditch, or followers you've overlooked with FriendOrFollow.
17. Find People: With Twitter's Find People tool, you can find or invite the people in your email address books to join you on Twitter.
18. Tweepsearch: Search Twitter bios and find recruiters using this tool.

Organization

Stay organized in your Twitter job search with these tools.

19. TweetDeck: Use TweetDeck to categorize your Twitter feeds, separating contacts with job listing feeds, and more.
20. Twuffer: Use Twuffer to compose and schedule future tweets.

19. Flock O'Tweets: This Twitter tool allows you to get feeds of multiple Twitter users sent to you by RSS.
20. Tweepler: Organize your followers and friends with the help of this app.
21. Splitweet: If you're using separate Twitter accounts for different functions, Splitweet can help you out.
22. Twit.io: Twit.io offers a social micro database that works as a solution to list jobs and more.
23. twtjobs: twtjobs is a simple career manager Twitter app.

Monitoring & Research

Stay on top of job alerts with the help of these tools.

26. TweetBeep: Set up alerts to find out about jobs as soon as they're tweeted with the help of TweetBeep.
27. TweetMyJobs: Subscribe to Twitter channels for jobs types and major cities, then get instant notification of new jobs on Twitter from TweetMyJobs.
28. TwitterHawk: Find people talking on Twitter about your chosen topic and location using TwitterHawk.
29. Twilert: Use this Twitter application to get regular email updates about tweets containing your brand, name, keyword, and more.
30. Twitter Job Alerts: Get direct messages sent to your Twitter account that match your CareerBuilder searches by setting up alerts with Twitter Job Alerts.
31. ConnectTweet: Learn about what's going on inside companies using ConnectTweet.
32. Monitter: Monitter can be used to find information about companies and find conversations about them.
33. Tweet Tag: Browse popular topics on Twitter and join in the conversation with Tweet Tag.

Your Message

Make the most of your Tweets by using these tools.

34. VisualCV: Link your online resume created on VisualCV on your Twitter bio.
35. PingVine: Use PingVine's service to automatically post an RSS feed from your blog to Twitter.
36. HashDictionary: Become a part of a group by using their hashtag. You can find the most popular and usable ones on HashDictionary.
37. HelloTXT: Make the most of your tweets by simulcasting them to Facebook, LinkedIn, and more.

Advice & Professionals

Learn all about job searching on Twitter and beyond from these professionals and advice feeds.

38. @exectweets: @exectweets will help you find and follow business executives on Twitter.
39. @cbsalary: @cbsalary shares news and tools for job seekers who want to learn about salaries.
40. @jobsearchnews: Here you'll find tweets full of the latest job search news.
41. @JobAngels: The guardian angels on @jobangels can help you find a job, and assist you when you help others find a job as well.
42. @PinkSlipParty09: Network with Pink Slip Party to help others find jobs, and find one for yourself as well.
43. @theonlinebeat: Use @theonlinebeat as a meta-engine for finding a job on Twitter.
44. @careertips: Get tips on your career with the help of Career Opportunities Broadcast.
45. @workerswork: @workerswork shares career, job, and work related news.
46. @JobHuntOrg: Susan Joyce is the owner of an award winning employment portal, Job-Hunt.org.
47. @jobwisdom: Get tips and advice for job hunting on @jobwisdom.
48. @PRjobs: Learn about Public Relations recruiting from Lindsay Olson.
49. @MonsterCareers: Get career advice and discussions from Monster.com.
50. @SimplyHired: Simply Hired works to make your job search simple and effective.
51. @CAREERALISM: Get advice from top career experts and be alerted about opportunities through @CAREEREALISM.
52. @snagajob: Get help with your part time or hourly job search from @snagajob.
53. @jobhunting: Jim Stroud shares happy news from the job market.
54. @ResumeBear: Follow @ResumeBear to learn how you can advance your career and improve your resume.
55. @jobnob: Learn about real salaries and find a job with Jobnob.
56. @jobshouts: Jobshouts is a great tool for finding a job through social media.
57. @workhappynow: @workhappynow encourages people to be happier with their work.
58. @BrazenCareerist: Get inspired to define your career and control your life by @BrazenCareerist.
59. @microjobs: @microjobs works to connect people with new opportunities on Twitter.
60. @applicants: @applicants shares information about jobs, freelancing, and more.
61. @cheezhead: Joel Cheesman stays on top of Internet recruiting here.
62. @tferriss: Tim Ferriss can teach you about loving your work more.
63. @twtjobs: Use @twtjobs, a simple Twitter career management app.
64. @CBforJobSeekers: Follow CareerBuilder's top job search experts here.

Job Listing Feeds

These feeds offer a direct line to job postings on Twitter.

65. @Elance_Jobs: Find out about the latest featured jobs on Elance.com here.
66. @freelance_jobs: Learn about fresh freelance jobs straight from @freelance_jobs.
67. @doscareers: @doscareers lists careers in Foreign Affairs.
68. @rocketjobs: Follow @rocketjobs to get updates about the best jobs in Ireland.
69. @thejobsguy: Ken Horst shares online recruiting and job search resources as well as new postings every day.
70. @hiremymom: @hiremymom works to connect at-home professionals with jobs and projects.
71. @RecruitDirect: Find direct jobs in Ireland on this Twitter account.
72. @HRCrossing: Check out @HRCrossing for the latest in HR jobs.
73. @media_pros: Find out about jobs for media professionals through @media_pros.
74. @joblister: Find work throughout the US and Canada from @joblister.
75. @myfirstpaycheck: Check out @myfirstpaycheck to find listings, resources, and more for teen job seekers.
76. @jobsitejobs: @jobsitejobs will send you personal job tweets to help you find work.
77. @travelnursejob: Follow @travelnursejob to learn about travel nursing opportunities throughout the US.
78. @37jobs: Get listings from the 37signals job board on @37jobs.
79. @elance: Learn about freelance opportunities through @elance.
80. @web20jobs: Check out @web20jobs for a real time tracker of Web 2.0 jobs.
81. @authenticjobs: Learn about savvy, authentic jobs available through @authenticjobs.
82. @journalism_jobs: @journalism_jobs will alert you to jobs in journalism, editorial, PR, and media sales.
83. @twitjobsearch: @twitjobsearch is the first semantic job search engine for Twitter.
84. @euractivjobsite: Follow the EurActiv JobSite to get an EU job of the day.
85. @execSearches: @execSearches connects talent with perfect positions.
86. @odesk: Follow @oDesk to be a part of the marketplace for online workteams.
87. @socialmediajob: Find your social media job on social media through @socialmediajob.
88. @newretailjobs: Get the hottest retail job opening leads every 30 minutes from major cities through @newretailjobs.
89. @juicyjobs: With @juicyjobs, you'll learn about green jobs in the UK.
90. @execjobs: ExecJobs finds six figure jobs for executives on Twitter.
91. @indeed: @indeed is a job search engine that aggregates all of the most important job sites.
92. @jobsearch: Emurse's Twitter feed offers listings, advice, and more.
93. @manpower: Find out what Manpower is recruiting for on this feed.
94. @Joblighted: @Joblighted offers a feed of Twitter tech jobs.
95. @publishingjobs: This feed will alert you to jobs in publishing available on Twitter.
96. @startuphire: @StartUpHire will alert you to jobs available at startups backed with venture capital.
97. @seojobs: Check out @seojobs to learn about SEO/SEM jobs available in the US.
98. @WorkInSports: Make your passion your career by finding a job through @WorkInSports.
99. @JobWire: Follow @JobWire to learn about the best jobs in Australia.
100. @krop_jobs: @krop_jobs updates on the latest creative and tech jobs.

• Email This
• Print
• Comments (4)
• Trackbacks
• Share Link

While life sciences companies are still reluctant to take the “social media plunge,” many other companies (with active social media programs) frequently hire employees known as social media managers who oversee and run their social networks.  This is because successful social media websites require daily attention and are extremely time consuming and labor intensive. In general, employees who are hired for these jobs have strong backgrounds in social media and technology but frequently possess little expertise in the industry that they are working in. Because social media is so new, many hiring managers believe that the social media and technology skills of these managers are more important than an understanding of the industry that they work in. However, while this practice may be acceptable in other industries, it won’t be the case for the social media managers who oversee pharmaceutical, biotechnology and medical devices and diagnostics social media websites. These managers will likely be required to have a firm understanding of current rules and regulations guiding drug development and marketing and advertising of approved life sciences products. This will be necessary if the drug makers who hire these managers want to steer clear of regulatory scrutiny by the US Food and Drug Administration and other regulatory agencies.

Based on my experiences as an industrial scientist and more recently as a social media manager, a person with a PhD degree with at least one course in regulatory affairs, good oral and written communication skills and an interest in social media ought to be an ideal candidate for these positions. To that end, those of you who may be interested in this newly, emerging career path option ought to begin training as soon as possible—these jobs will be in high demand at life sciences companies, medical communications agencies and conference organizers in the next year or so!

Until next time....

Good Luck and Good Job Hunting!!!!!!!!!!!!

• Email This
• Print
• Comments (1)
• Trackbacks
• Share Link

The debate, if you can call it that, over whether or not interactive social media platforms like Facebook and Twitter can be used in the life science industry is moving forward at glacial speed. I decided that it was time to propose some ideas rather than continue to admonish the US Food and Drug Administration (FDA) for a lack of guidance.

There are several reasons which may explain the inertia surrounding the adoption of social media by pharmaceutical, biotechnology and medical devices and diagnostics companies. First, and perhaps foremost, FDA has been consistently reluctant to craft any useful guidance on the use of Web 2.0 technologies for research, clinical or promotional purposes. The FDA’s Division of Drug Marketing, Advertising and Communications (DDMAC) is still trying to figure out how to regulate website content. Is it any wonder that FDA is reluctant to tackle the regulatory implications and issues associated with social media platforms like Facebook and Twitter? Second, a majority of social media advocates— who are leading the charge at many life sciences companies—are marketing and advertising executives who tend to look at social media strictly as a promotional tool. Finally, much of what takes place at life sciences companies is proprietary and confidential—information flow between the company and its employees and the public is fastidiously monitored and tightly regulated. Because of this, the life sciences industry’s “process” is intentionally opaque—which is contrary to the goals of social media which is to promote transparency (or the illusion of it).

There is no doubt that the life sciences industry is the most highly regulated industry on the planet. While this represents a formidable challenge for adoption of social media, it is by no means insurmountable—especially if social media is used for purposes other than branding, marketing and advertising. For example, the most straight forward application of social media at life sciences companies would be in the areas of corporate recruitment and employee retention. Many Fortune 500 companies outside of the life sciences industry have been using Facebook, MySpace and LinkedIn for years for recruiting purposes. While not commonly acknowledged, life sciences companies have quietly begun to use Facebook, LinkedIn and MySpace to recruit prospective employees. Interestingly, the new kid on the block—Twitter—looks to potentially be a more powerful recruiting tool than any of its predecessors. Unfortunately, employee retention is no longer a priority at many companies. However, before the economic meltdown a number of companies, most notably Best Buy, were experimenting with social media to retain talented employees.

Another potential use of social media is for pharmacovigilance and adverse events reporting. Companies with approved products on the market are required by FDA (and other regulatory agencies that approved their products) to set up post marketing surveillance programs for adverse events reporting. By law, companies that receive adverse events reports from consumers, physicians or other entities must report them to the regulatory agencies that approved the product. Regulatory agencies maintain adverse events databases for all approved drugs and devices to monitor drug safety.  If designed and implemented correctly, interactive social media platforms like Facebook and Twitter (which operates in real-time) would make excellent pharmacovigilance and adverse reporting tools. Quite coincidentally, John Mack, who runs the Pharma Marketing Blog, reported a partnership between UCB and PatientsLikeMe.com to create a pharmacovigilance reporting platform for UCB products.

Recruiting patients for participation in clinical trials (to assess efficacy and safety of prospective new drugs) has become extremely challenging over the past few years.Traditional patient recruitment strategies include print, television and radio ads and in some instances, websites. All of these recruitment methods are costly, labor intensive and limited in their effectiveness because they only reach small number of prospective clinical trial participants. I contend that Facebook with over 200 million users, LinkedIn with members in over 140 different countries and Twitter which is growing rapidly would be ideal for clinical trial recruitment and retention purposes. Others have also proposed this idea.

Finally, while the use of social media to promote approved drugs and devices may be difficult because of regulatory constraints, it can be utilized to keep the public informed about prospective new medicines and promote a company’s image or brand. There is no question that the public perception of the pharmaceutical industry has been severely tarnished over the last few years.  The industry’s continued lack of transparency and failure to adequately disclose potential safety risks about some approved products continues perpetuate a negative image. One way to restore public trust and confidence is to use social media to actively engage the public in conversation on wellness, addressing unmet medical needs and prospective new medicines and treatments that are being developed. Also, social media platforms could be employed to showcase community outreach programs and discuss educational initiatives to improve science education and training.

Social media is no longer a new phenomenon or technology. It is a legitimate form of communication which has become an integral part of the Web 2.0 experience. I suspect that the life sciences industry will have to make a decision about social media in the not so distant future—or possibly miss a potentially game-changing business opportunity. And, as Ken Kesey aptly said in Tom Wolfe’s ‘The Electric Kool-Aid Acid Test’—“You’re either on the bus…or off the bus.”

 Until next time...

 Good Luck and Good Job Hunting!!!!!!!!

• Email This
• Print
• Comments (4)
• Trackbacks
• Share Link

Mark Sendak, a social media enthusiast and author of the Eye on FDA blog, wrote a great post today about an article he saw in the Washington Post entitled “Drug Firms Jockey for Space Online.”

Mark wrote: “Flock?  Flock?  FLOCK?  The only way you could use the term "flock" in connection with pharmaceutical firms and social media is to say that companies are a scared flock of geese.” He goes on to castigate FDA’s Division of Drug Marketing, Advertising and Communications (DDMAC) for a lack of a coherent regulatory framework and guidance for the use of social media in the life sciences industry.

Mark aptly describes DDMAC’s guidance surrounding social media and the pharmaceutical industry this way. “No one knows, and DDMAC apparently makes this stuff up as they go along. That is the kind of Whack-a-Mole game DDMAC plays.  We won't tell you what is off limits, until you do it and then WHACK! Is this anyway to run a pharmaceutical industry?

I am in total agreement with Mark on this issue. Despite the rapid adoption of social media by other industries, FDA has consistently been reluctant to issue any regulatory guidance what so ever on the topic despite assertions to the contrary. Unfortunately, when it comes to social media and the pharmaceutical industry, FDA’s usual approach to regulatory guidance—reactive rather than proactive—is still alive and well. As you may recall FDA previously sent warning letters to no fewer than 14 pharmaceutical and biotechnology companies admonishing them on their placement of product ads on search engine results pages. The fact that 14 different companies received warning letters on this issue reflects the confusion and lack of guidance offered by FDA on social media and the use of Web 2.0 technologies to promote or support the sale pharmaceutical products.

The growing popularity and inevitability of social media suggests that DDMAC officials along with industry representatives must begin to consider crafting a preliminary regulatory framework for its use in the life sciences industry. Like it or not, social media is here to stay!

Hat tip to EyeonFDA!

Until next time....

Good Luck and Good Job Hunting

• Email This
• Print
• Comments
• Trackbacks
• Share Link

As many of you may know, I attend national science meetings where I offer resume critiquing services and give career development seminars on topics ranging from resume writing to alternate career opportunities for life scientists. Frequently, I critique the resumes of foreign PhD students and postdocs who want remain in the US but cannot for a variety of reasons related to visa status. I usually tell them that there are more job opportunities for them in their home countries; usually India and China, than there are in the US which no longer has a great demand for R&D scientists. 

Until recently, I hadn’t heard of any Asian recruiting firms or organizations that would help to find jobs for US-trained life scientists. Much to my surprise, I heard from Shyam Suryanarayanan, an entrepreneur who started a recruiting organization called ABLE C-Drive that helps place US-trained Indian nationals into life science jobs at Indian pharmaceutical and biotechnology companies.   I asked Shyam to send me a description of the services offered by ABLE C-Drive. Here is what he wrote:

"ABLE C-DRIVE (www.cdrivejobs.com) is a specialist Life Science Career Platform for the Indian Life Science Industry.  It is an initiative launched by C-DRIVE ( a specialist Life Science Career Solutions Company), in collaboration with ABLE - (Association of Biotechnology Led Enterprises), the Industry Association and the face of the Indian Biotech sector. The company is a pioneering initiative in the Indian Life Science Careers space to help Life Science Professionals be accessible/visible to a whole host of hiring organizations in a discreet manner, with a view to getting hired.  The 'Returning Indian' Community is a preferred group, given their strong training and experience in World Class research labs.

The list of companies hiring from this platform includes a mix of large global home grown leaders, as well as exciting small and medium-sized outfits across pharma, biotech, agricultural sciences (nutraceuticals), bioinformatics, clinical research, contract research and manufacturing." 

Our platform is a boon to hiring companies, because it is a single destination for pre-screened, quality life science professionals which significantly lower the cost, time and effort required for hiring. For additional information, please visit www.cdrivejobs.com or send your resume to lifejobs@cdrivecareers.com”

Those of you who are seeking life sciences jobs in India ought to check ABLE-C Drive out!

Until next time...

Good Luck and Good Job Hunting!!!!!!!!!!

• Email This
• Print
• Comments (1)
• Trackbacks
• Share Link

After yesterday's post about career planning for life scientists, one of my soon to be former students in the Fundamentals of Bioscience Program aptly pointed out that my readers might have benefitted more if I had, in fact, offered information about alternate career possibilities for bioscientists.  I don't want the student to get too overconfident but I had the same thought immediately after I uploaded the post.  

Rather than modify the previous post, I decided to upload the presentation that I gave to the U Penn Graduate Student Biomedical Association yesterday.  However, as many of my former (or soon to be former) students will tell you, my PowerPoint presentations, while informative, are not as complete as you might think.  To get the real skinny on alternate careers, you will have to attend one of my seminars on the topic where I provide attendees with additional pearls of wisdom and some funny stories about my own journey along an oft times circuitous career path!

Until next time.....

Good Luck and Good Job Hunting

• Email This
• Print
• Comments
• Trackbacks
• Share Link

Yesterday, I gave a lecture entitled “Alternate Careers: Taking the Road Less Traveled” to over 100 members of the University of Pennsylvania’s Biomedical Graduate Student Association. As always, there were many good questions and comments during and after the presentation. Some of the career anecdotes offered by several of the students reminded me of a conversation that I had several weeks ago with one of my Fundamentals of Bioscience students—I teach a Product Development and Regulatory Affairs course in the program—who refreshed my memory about a typical graduate student approach to career development and job searching. “We don’t think about jobs or our careers until we begin writing our PhD theses” she said. “Until then, our advisers don’t talk about careers or jobs and only bring it up because our funding will run out” she added. Admittedly, I had forgotten this because so many years have passed since my graduate student days. That said, it forced me to consider how much the life sciences job market has changed since I was graduate student and how vitally important it is for today’s graduate students to think about and possibly explore different career options throughout the course of their graduate training.

Historically, there were very few career options for life scientists—it was either a tenure track faculty appointment or, as a poor second choice, a job at a pharmaceutical or biotechnology. Unfortunately, academics jobs are hard to come by and since 2007 over 60,000 pharmaceutical R&D scientists have lost their jobs and more cuts are expected. Also, many of these jobs are likely come back after the economy improves because many of the R&D activities performed by these scientists are being outsourced to India, China and elsewhere. This suggests that a majority of life sciences graduate students who receive their PhDs within the next few years won’t be able to secure traditional life sciences jobs. While a majority of US life sciences graduate training programs recognize and understand the implications of the changing job market, many are reluctant to discuss alternate career options with graduate students and postdoctoral fellows. Even fewer, encourage or support students or postdoctoral fellows who want to engage in “extracurricular activities” to explore alternate career options. In fact, several U Penn students told me that they have to obtain written permission from their adviser before they can take courses or participate in extra-departmental activities. As one student quipped “What I do on my own time should be my business not my boss's.”

I always conclude my alternate career talk by saying “Nobody ever guaranteed you a job after completion of your PhD or postdoctoral training.” And, “if you wanted a job after completing your education, you ought to have gone to medical school, dental school, law school or any other profession that requires licensure to practice your craft.” While this may sound harsh, I believe that the decision to get a PhD is a personal one and based on discussion with many of my colleagues, most didn’t enter graduate school expecting a job to be waiting them when they completed their training. Nevertheless, I contend that graduate departments that continue to train and prepare students for traditional academic careers —knowing that over 90% won’t find jobs (other than postdocs) after their training is finished —are being disingenuous and even deceitful. Why haven’t academician realized that there is a plethora of job opportunities for life scientists outside of academia?

Like it or not, the life sciences job market has undergone radical changes in the past decade. Unfortunately, academics continue to adhere to dogmatic and anachronistic ideas and practices that don’t prepare their students and postdoctoral fellows for jobs in “the real world.” I contend that informing and enlightening graduate students about alternate career paths and, allowing them to explore some of these opportunities will not impede or hinder laboratory research. Instead, I believe it would help to improve and expedite its progress. As one U Penn graduate student shared with me over a couple of beers “If they would just tell us the truth and give us some idea about our options, it would certainly improve morale, reduce our anxiety and allow us to focus on our research because we would know what is out there!” As the old adage goes”ignorance is bliss.” But, in my experience, knowledge is power!

Until next time....

Good Luck and Good Job Hunting!!!!!!!!!!

• Email This
• Print
• Comments (1)
• Trackbacks
• Share Link

Over the past three years, more than 90,000 pharmaceutical employees have been layed off. While many of these former employees were drug reps, a majority who lost their jobs were R&D scientists. If drug makers have already jettisioned tens of thousands of R&D jobs, how is the next generation of medicines going to be discovered and developed? Like it or not, pharmaceutical and biotechnology R&D is beginning to be outsourced—much like information technology (IT) was in the late 1990s. And, like the IT industry much of R&D is being outsourced to countries like India and China. This should not be surprising because for the past 20 years or so, most of the people receiving PhDs in the life sciences were foreign nationals—many of whom were unable to stay in the US because of post-9/11 immigration policies and visa quotas. Without many options, many had no choice but to return to their home countries to seek employment and in some at contract research organizations (CROs) that specialize in pharmaceutical and biotechnology R&D.

According to a recent article written by J B Gupta Senior Vice President Collaborative Research GVK Biosciences Pvt. Ltd. India, for the last five years or so, Indian CROs like GVK Biosciences, Aurigene, Syngene, Advinus, Jubilant, Suven Life Sciences, Sai Lab, Accunova, iGate etc. have been positioning themselves as purveyors of R&D services to pharmaceutical and biotechnology companies. These efforts have apparently paid off! Companies like Merck, GlaxoSmithKline, Forrest Laboratories, Eli Lilly & Co, Johnson & Johnson, Merck Serono, Wyeth, Bristol Myers Squibb and others have entered into strategic R&D partnerships with many of India’s leading CROs. 

A recent study by the Kauffman Foundation suggests that India better positioned and ahead of China in R&D outsourcing. Further, the pace at which discovery collaborations are being established in India suggests that the western pharmaceutical industry is looking to Indian CROs not only to cut costs but to innovate as well.

Unfortunately, while this doesn’t bode well for American scientists, the US has nobody to blame but itself. Wrong-headed immigration policies coupled with inadequate training for life scientists who want to pursue industrial careers are largely responsible for the current R&D outsourcing activities. Like IT, I suspect that outsourcing will work for some companies but not others. Nevertheless, I think that outsourcing is here to stay and like it or not American life scientists will have no choice but to adapt to the “new normal.”

Until next time...

Good Luck and Good Job Hunting (try India or China)

• Email This
• Print
• Comments (4)
• Trackbacks
• Share Link

Medtronics, the world's largest medical-device company, announced today that it will lay off 1,500-1,800 employees after posting a fiscal fourth-quarter profit that plunged 69 percent on slipping sales,restructuring and other charges. About 400 employees already have accepted buyout offers and will leave the company by the end of the month.

Until now, the medical devices and diagnostic industries, unlike pharma and biotech had had remained unscathed by the current economic downturn. Medtronic’s financial woes are mainly a result of questions about its implantable devices which have come under fire recently because of safety concerns. Nevertheless, don’t be surprised if you see other medical devices and diagnostic companies begin to layoff workers as the financial crisis deepens and medical and healthcare costs continue to rise.

Hat tip to Iguana Bio.

Until next time...

Good Luck and Good Job Hunting!!!!!!!

• Email This
• Print
• Comments (1)
• Trackbacks
• Share Link

The Biotechnology Industry Organization (BIO) kicked off its annual meeting in Atlanta, Georgia today and shortly thereafter, issued a press release detailing an education study (that it commissioned) which suggests that American high school students are continuing to fall behind in life sciences education and competitiveness. The timing of the BIO education report is curious, given that over 100,000 life sciences employees have lost their jobs over the past several years and more job cuts at pharmaceutical and biotechnology companies are expected in the next six months or so.

The report concluded that “middle and high school students across the country are generally falling behind in life sciences, and the nation is at risk of producing a dearth of qualified workers for the life sciences industry. Students are showing less interest in taking life sciences and science courses, and high schools are doing a poor job of preparing students for college-level science, The deficiencies will hurt the country's competitiveness with the rest of the world in the knowledge-based economy.”

Some of the report's finding include:

• 52 percent of 12th graders are at or above a basic level of achievement in the sciences as measured by the NAEP science test
• Average scores on the NAEP for 12th graders in the sciences and life sciences declined from 1996 to 2005
• Only 28 percent of high school students taking the ACT reached a score indicating college readiness for biology.

The report also found a deficiency in the number of well-qualified biology teachers available in high school, with one-in-eight biology teachers not certified to teach biology. To improve U.S. competitiveness in the biosciences industry, the report recommends that states incorporate biotechnology into their science standards, make sure students are ready to take college biosciences courses and focus more on professional development for teachers.

While BIO ought to be commended for the study, the results and the conclusions of the report are nothing new and have been known for over a decade by industry thought leaders and life sciences industry executives. The crux of the problem is that neither academia nor industry is willing to provide funds or invests in ways to find a solution to this vexing, ongoing issue. Also,while high school science curriculum experts and teachers are typically cited as the cause of the problem, most of the blame more aptly lies with life science educators at the undergraduate and graduate school levels.

Today, many US high schools and community colleges already offer life sciences and biotechnology training to their students. In fact, biotechnology curriculum development and outreach has been ongoing in US for well over a decade. For example, Bio-Link, an NSF-funded consortium of community colleges that began in the late 1990s, has diligently worked to create a network of community colleges and high schools that offer biotechnology education and training ranging from biomanufacturing to bioinformatics to forensic DNA sciences. Further, a quick perusal of many high schools and science academies in biotechnology-rich locales like the Northeast, California, New Jersey, Maryland, North Carolina and others reveals that life sciences education and training are readily available to many students interested in biology and bioscience.

In my opinion, the system doesn't break down at the high school level but at the undergraduate and graduate school levels. This is because for the past 15 years, many undergraduate life sciences courses have jettisoned their hands on laboratory components in favor of more lecture driven and e-based learning experiences. This is because these laboratories are costly to run and extremely labor intensive. Further, many undergraduate students may choose not pursue science careers because of the mistaken perception that life sciences jobs require a PhD. Ironically, there are many more jobs in the life sciences industry for students with undergraduate or masters' degrees than for those with PhD. This is because there is a glut of PhDs in today's market and the number of jobs in academia and the life sciences industry are growing smaller. I believe that academia and industry are responsible for the rapidly declining job market for PhD-life sciences.

First, let's look at academia. Most academicians who are charged with training PhDs and postdoctoral fellows have little appreciation or understanding of the technical and regulatory skill sets required in the life sciences industry. Second, many academics don't feel that it is their responsibility to prepare students and postdoctoral fellows for jobs in industry because that is tantamount to job training—a big no-no in academic circles. Finally,and perhaps most important, graduate programs are reluctant to provide career counseling or job-specific training for their students because it might interfere with their productivity, which in turn may reduce the amount of data principal investigators have to write papers and win grants to fund their laboratories. In other words, there is little or no incentive for education and training to change at the graduate level because there is no benefit or upside to principal investigators and tenured faculty members.

While the American life sciences industry has loudly and repeatedly complained about a lack of qualified job candidates to work at its companies, they have done little to support and fund efforts to reform US life science education and training. This is likely because many life sciences executives contend that they are in business not education and the responsibility to prepare students for careers in science should not fall on them. Rather, it rightfully belongs in the purview of secondary and post secondary educational institutions. And, rather than train new employees without previous industrial experience (to inject new talent and ideas into their organizations), companies typically only hire job candidates with previous industrial experience. As many newly minted PhD and postdoctoral students frequently ask: “How are we suppose to get industrial experience if nobody will hire us without previous industrial experience?” Good question! 

The BIO report warns that the US is falling behind in bioscience education and American life science companies may experience workforce shortages in the future. The fact that about 100,000    (many of whom were scientists) pharmaceutical employees have lost their jobs over the past several years, suggests otherwise. Nevertheless, American science education and training needs to be improved and reformed if the US wants to maintain its dominance in the life sciences. The piecemeal approach that has been pursued for past decade or so hasn't worked. And why should it? Neither academia nor industry, the two main players in the story, don't really have any “skin in the game.” In other words, they have nothing to lose right now!

I believe that its time for academia, industry and government to come together to craft a cohesive, national life science curriculum that meets the needs of all stakeholders. We have a President in the White House who believes in science, the ingenuity of the American people and change. The time is now!

Until next time...

Good Luck and Good Job Hunting!!!!! 

• Email This
• Print
• Comments (1)
• Trackbacks (1)
• Share Link

Over the past several years, I have publicly called for fundamental changes in graduate education and training for life scientists. To that end, I was delighted to read an OP-ED piece in today’s New York Times entitled “End Universities as We Know It” written by Professor Mark C. Taylor, Chairperson of the religion department at Columbia University. 

In his post, Professor Taylor recommended several fundamental and systemic changes that ought to improve the likelihood that graduate students and postdoctoral fellows find jobs at the end of their graduate education. While some of Dr. Taylor’s ideas are novel and innovative, two in particular; 1) expanding the range of career opportunities for graduate students and postdocs and 2) abolishing tenure and mandatory retirement; are ones that I have suggested many times in the past few years. Rather than paraphrase, I decided to repost what Dr Taylor said about these two very important, seminal issues.

Expand the range of professional options for graduate students

Most graduate students will never hold the kind of job for which they are being trained. It is, therefore, necessary to help them prepare for work in fields other than higher education. The exposure to new approaches and different cultures and the consideration of real-life issues will prepare students for jobs at businesses and nonprofit organizations. Moreover, the knowledge and skills they will cultivate in the new universities will enable them to adapt to a constantly changing world.

Impose mandatory retirement and abolish tenure

Initially intended to protect academic freedom, tenure has resulted in institutions with little turnover and professors impervious to change. After all, once tenure has been granted, there is no leverage to encourage a professor to continue to develop professionally or to require him or her to assume responsibilities like administration and student advising. Tenure should be replaced with seven-year contracts, which, like the programs in which faculty teach, can be terminated or renewed. This policy would enable colleges and universities to reward researchers, scholars and teachers who continue to evolve and remain productive while also making room for young people with new ideas and skills.

For many years now, I have been struggling with the moral and ethical obligations of graduate education. Recently, I came to the conclusion that it is our role as educators to selflessly impart knowledge and training to graduate students and postdoctoral fellows so that they can pursue the careers (and lives) that many have trained for a decade or more. I think Professor Taylor’s view of the role of an educator says it best: “Do not do what I do; rather, take whatever I have to offer and do with it what I could never imagine doing and then come back and tell me about it.” This is the attitude that must be by academicians if America wants to remain competitive in the life sciences.

Until next time....

Good Luck and Good Job Hunting!!!!!!!!

• Email This
• Print
• Comments
• Trackbacks
• Share Link

While I was at the Experimental Biology meeting in New Orleans, LA this past week I presented a seminar entitled “Using Social Media For Career Development in the Life Sciences.” This was the first time that I presented this talk, and was expecting a large turn out given the popularity of Facebook and more recently Twitter, a microblogging platform.  Much to my surprise only 15 students showed up for the talk—many of whom hadn’t heard of Twitter and were only vaguely familiar with Facebook. Luckily, a few attendees had Facebook profiles and one or two were on Twitter so the talk wasn't a complete bust.  Nevertheless, the lack of interest in this talk was extremely puzzling to me—my other seminars, “Interviewing Tips” and “Alternate Careers for PhDs” were very well attended and I was booked solid for one-on-one resume critiquing sessions during the five days I was in New Orleans.

I started to wonder why bioscience graduate students in their mid to late 20s, many of whom will need to find jobs (postdocs otherwise) in the next few years, weren’t interested in learning how to use social media to advance their careers or conduct a job search.  I thought that the lack of interest in this topic might be explained if a majority of graduate students and postdoctoral fellows were already using Facebook, Linked In or Twitter to network or explore career opportunities. This proved not to be the case, after learning that only a small percentage of students (who sought career counseling) had considered using social media to network or look for jobs. While many had Facebook profiles, most students primarily used them to stay in touch with friends and family—not for professional or scientific purposes. 

The lack of interest in social media for career development  by many of these nascent GenY scientists was confounding. After all, I have been lead to believe that “GenY” is leading the Web 2.0 and social media charge and that aging boomers like me simply “don’t get it.” The fact that I get it and many  GenY scientists, don’t forced me to revisit what I learned about the social behavior of scientists over the past 30 years or so.

First, it is no secret that scientists aren’t the most  socially-adept individuals and when socializing it tends to be very “cliquish” and oft time exclusive.  Second, scientists are notoriously poor networkers and mostly engage in serious networking when alcoholic beverages are involved.  In other words, very little networking takes place in professional and scientific settings with the exception of  conferences and meetings. Finally, and perhaps most importantly, many of the academicians who train scientists don’t understand networking and often don’t offer any career guidance to their students and postdocs. Unfortunately, most academics have little or no understanding of the world outside of academia and, not surprisingly, there is little incentive for them to learn about it—mostly because of the anachronistic tenure system. Further, because PhDs are taught to be independent and self reliant, there is almost no emphasis placed developing social skills during their training.   In fact, many academics believe that being too social is the best way to be “scooped” by their competitors. Paradoxically, there are currently over 30 social networking sites for scientists (including BioCrowd, the career development networking site that and I started). I suspect that many of us who started these sites recognized an opportunity to use social media to bring scientists together on the Web in a less threatening way than IRL. Although several of these sites report high subscription rates, it is not clear how effective they are for networking and career development purposes.

The job market for life scientists has been extremely difficult and competitive for the past five years or so. Academic positions are still hard to come by and the recent downsizing that has taken place in the life sciences industry—about 85,000 jobs have been lost in the past three years— suggest that competition for life sciences jobs will remain fierce for the foreseeable future. Like it or not, graduate programs must begin to provide job counseling and offer career development training to their students and postdoctoral fellows—their lives may depend upon it. 

Until next time....

Good Luck and Good Job Hunting!!!!!!

• Email This
• Print
• Comments (1)
• Trackbacks
• Share Link

Are you a life sciences or healthcare professional with a passion for computers, IT or software development? If so, you might want to consider a career in health informatics—one of the hottest, new fields in the life sciences and healthcare industries. Health informatics specialists typically have expertise in medical records and claims, clinical care and programming. In other words, they have a foot in two worlds— medicine and technology — and can easily bridge the often daunting gap between them. It is important to point out that there is a difference between healthcare IT and informatics personnel. The health IT people run the servers and install software, but the informatics people are the ones who analyze and interpret clinical/ medical information and work with clinical and other healthcare staff to advise and help them.

According to an article in this Sunday’s NY Times, health informatics specialists usually start as computer programmers or as doctors, nurses, pharmacists or health record administrators. After earning a graduate health informatics degree, they find jobs as mid level or senior employees at hospitals, doctor’s offices, insurance companies, pharmaceutical companies or other organizations concerned with health data. Mid level jobs, like those for clinical analysts or informatics analysts, are usually about $70,000 a year, but salaries can be much higher for more senior level positions.  Senior level jobs, which sometimes require a Ph.D., include chief clinical information officer or other management/leadership roles at medical devices, life sciences or insurance companies. Consulting firms are also hiring health informatics experts to serve many of their health care clients who frequently don’t have the resources to hire permanent informatics staff.

At present there are no educational, licensing or credential requirements to become a health informaticist. However, a growing need for health informaticists has resulted in the creation of a number of degree programs at two and four year colleges and universities. For example, within the past four years, Columbia University, St. Louis University, the University of Minnesota and Oregon Health and Science University have all added master’s programs or certificates in health informatics. Other schools offer short courses or part-time certificate programs to healthcare employees or programmers. Still others are adding undergraduate majors or associates degrees programs to their curricula.

While many schools are beginning to offer health informatics programs, not all informatics programs are “created equal.” Generally speaking, “medical” or “biomedical” informatics programs focus on data that doctors need for treating patients. Bioinformatics” programs concentrate on biological or genetic data, while “health informatics” programs often emphasize clinical data and health records. Even among programs with the same name, the emphasis and expertise may vary at different institutions that offer the training.

By all accounts, health informatics —despite some early confusion—is one of the fastest growing careers in the bioscience and healthcare fields. Unlike other fields in the shrinking life sciences industry, there are plenty of jobs out there for health informaticists. Ironically, the failing US economy is what is driving the growth of the health informatics industry. The US government’s economic stimulus package has allocated $19 billion to hastening the adoption of electronic health records, so demand for health informatics specialists is skyrocketing. “My rough estimate is that we need about 70,000 health informaticists,” said Don E. Detmer, president and chief executive of the American Medical Informatics Association, a nonprofit industry group.

However, as a word of caution, it usually takes more than technical skills and an understanding of health care to succeed as a health informaticist. Diplomacy and conflict resolution skills are crucial when dealing with two potentially contentious groups: healthcare workers and programmers. Nevertheless, healthcare informatics is an ideal field for bioscientists and healthcare workers who also like to work with technology, computers or develop software. Based on my recent experiences as a bioscience career counselor, I know that there are thousands of you out there that fit this description. Now be the time to take a closer look at the exciting, new field of health informatics to determine whether or not it may be a career option for you!

Until next time...

Good Luck and Good Job Hunting!!!!!!!!!!

• Email This
• Print
• Comments
• Trackbacks
• Share Link

Using Facebook and Twitter to find jobs is becoming routine in many industries including healthcare. However, the life sciences industry is lagging behind most others when it comes to social media and recruitment. Nevertheless, many companies and academic institutions are beginning to realize that Facebook (FB), Twitter and other science social networks are good source of qualified candidates for  those difficult-to fill job openings. 

Lindsey Pollak, a GenY career guru who, writes on the use of social media for job searching, alerted me to a post (via Twitter @biojobblog) that describes how to effectively use FB to find a job.  While FB may be useful to scientist looking for work, there are many other bioscience social networks like BioCrowd (@biocrowd) that regularly post jobs and career opportunities for life scientists.

Until next time...

Good Luck and Good Job Hunting 

• Email This
• Print
• Comments
• Trackbacks
• Share Link

As many of you know, the life sciences industry, one of the most highly regulated industries of the economy has been hesitant and reluctant to embrace social media to reach out to patients, physicians and the lay public. This is because the US Food and Drug Administration, specifically Division for Drug Marketing, Advertising and Communications (DDMAC), has been mute on the subject and hasn’t issue one iota of guidance on the use of social media in the pharmaceutical, biotechnology or medical devices/diagnostic industries.

Mark Senak, a regulatory affairs lawyer and owner of the blog eyeonfda.com, invited Dr. Jean Ah Kang, Special Assistant at DDMAC in charge of Web 2.0 policy development to talk about FDA’s views and ideas about social media and its use in the life sciences industry. Listening to the 15 min podcast would be, according to Mark, “time well spent” for social media advocates in the pharmaceutical, biotechnology and medical devices/diagnostics sectors.

Hat tip and much “love” to Mark who wrote “BTW, I absolutely expect waves of love for this (the podcast)."

Until next time....

Good Luck and Good Listening!!!!!!!!!! 

• Email This
• Print
• Comments
• Trackbacks
• Share Link

Facebook contends that it has over 175 million members, making it the largest social network in the world! Interestingly, according to an article in today’s New York Times, most US members are “still relatively young.” “Facebook offers advertisers a target of 54.4 million members of all ages. But if an advertiser wants to narrow its target audience to those 25 or older, the number drops to 28.8 million. Narrow it to those 30 or older, and Facebook has 20.3 million to offer.” However, this is not surprisingly because people 30 and over weren’t allowed to join Facebook until 2006. In fact, many over-30 individuals have yet to sign up! In support of this, I am increasingly getting friend requests from my contemporaries—most of whom are in their 40s and 50s.

Each week, a million new members are added in the United States and five million globally—the 30-and-older group is its fastest-growing demographic (and the one with the most money to spend).  Further, Facebook members are becoming increasingly social and gregarious. In December the average number of “friends” per member was 100. Since then, it has grown to 120 per member according to a Facebook spokesperson. If Facebook continues to grow at its current rate, it will likely experience unprecedented and astonishing growth in the next few years. And, when it comes to monetizing social networks, bigger is always better!

Until next time...

Good Luck and Good Networking!!!!!!!!!! 

• Email This
• Print
• Comments
• Trackbacks
• Share Link

This morning, while doing my usual Twitter review, I came across a tweet from the Scientist.com about John McCain’s recent anti-science Twitter rants.  Based on his tweets (and snarky comments) he considers the following projects blatant examples of pork barrel spending:

"$209,000 to improve blueberry production and efficiency in GA"

"$819, 000 for catfish genetics research in Alabama"

"$900,000 for fish management - how does one manage a fish"

Older McCain tweets include:

"$1,427,250 for genetic improvements of switchgrass - I thought switchgrass genes were pretty good already, guess I was wrong."

"$250,000 to enhance research on Ice Seal populations"

"$2.1 million for the Center for Grape Genetics in New York - quick peel me a grape."

"$650,000 for beaver management in North Carolina and Mississippi"

McCain’s tweets underscore how little politicians—especially republicans(what do you expect from a party that endorses intelligent design over evolution) —understand about how science works. That said, some of the proposed projects cited by McCain may require additional scrutiny (by science experts not him) and may turn out to be projects that don't warrant funding.  Nevertheless,I believe that McCain's tweets are part of a well crafted Republican-led initiative intended to publicly discredit  these earmarked projects so that he and other Republican's can redirect public monies to their own pork barrel initiatives. Shame on McCain and his cronies for attempting to hijack Twitter to discredit worthy scientific, environmental,agricultural and conservation projects. 

Let’s try to disrupt McCain’s plan by tweeting that he is anti-science! 

Tweet away peeps!

Hat tip to the The Scientist!

Until next time...

Good Luck and Good Twittering!

• Email This
• Print
• Comments
• Trackbacks
• Share Link

For the past decade or so, I have worked as a career counselor at national scientific meetings where I present seminars about resume writing, interviewing techniques and other career related issues. About two years ago, I started to hear about the fierce competition for H-1 and J-1 visas that foreign students must obtain to remain in the US to continue their studies and research. Many of the foreign students that I talked with sounded more like immigration lawyers than graduate students or postdocs—I was amazed at how well informed they were about visa availability and the changes and loopholes in US immigration law that can be exploited to obtain visas.

Since that time, it has become increasingly apparent that the visa problems experienced by most foreign students are beginning to wreak havoc on US science and engineering. Curiously, nobody at the US State Department seems to know why these visa problems exist. According to an article in today’s NY Times, a State Department official claims that visa delays can be attributed to “unfortunate staffing shortages.” Many of the students (and some immigration lawyers) that I talked with believe that it is annual visa limits and quotas not staffing issues that make it so difficult to obtain them.

It is no secret that American middle and high school students are no longer interested in pursuing careers in science and engineering. Because of this, American universities have come to rely on foreign students to fill open slots in graduate and postdoctoral sciences and engineering programs. With this in mind, it should come as no surprise that, over the past decade or more, foreign talent has been largely responsible for much of the technical and scientific innovation in the US.  Finally, and perhaps most importantly, American universities can no longer assume that the US is the first choice or destination for many foreign undergraduate, graduate and postdoctoral students—teaching and research at many foreign universities have vastly improved in recent years and can now compete with the best research institutions in the US.  In the past, it was largely assumed that when given a choice foreign student would choice a US university over all others. Together these findings beg the question: “If foreign students and postdocs are largely responsible for maintaining America’s competitive edge in science and technology, why would the US government make it so difficult to recruit the world’s best and brightest?”

There is no doubt that the US government, in a post-September 11^th world ought to carefully scrutinize foreign students before they are issued visas to study or work in the US. But, why has it become increasingly difficult for foreign students to renew their visas to continue to study or work in the US? Interestingly, visa availability and renewal problems are not only restricted to foreign nationals from likely places like China, India, the Middle East or Russia.  Many students and postdocs from Australia, Europe and elsewhere are also experiencing major delays and difficulty obtaining student or work visas.

While the visa issues facing foreign students may not seem like a big one to most Americans (most of who are not involved in science and engineering), its effects on American science and engineering are beginning to become apparent. For example, conference organizers are reluctant to hold international meetings in the US because they fear that many students and scientists will not be able to attend because of limited visa availability. Further, many talented foreign nationals, who want to remain and work in the US, are frequently forced to return to their home countries (to find employment) because they are unable to renew or extend their US visas. There is no question that America has grown increasingly dependent upon foreign students to conduct research in science and engineering.  I contend, that without these students, America’s competitiveness in science and engineering will continue to wane as it has over the past 20 years.  I believe that America has two choices to prevent this from happening. First, we can somehow convince larger numbers of American high school students to pursue careers in science and engineering. Second, the US government can improve and simply the visa process so that talented foreign students can continue to study and do research in the US. Nevertheless, something must be done soon—the future competitiveness of American science and engineering depends on it!

Until next time...

Good Luck and Good Visa Hunting!!!!!!

• Email This
• Print
• Comments (4)
• Trackbacks
• Share Link

Over the past ten years or so, pundits have been warning that the US is losing its competitive edge and that it is no longer the world’s leading nation when it comes to innovation in science and technology. Measuring national competitiveness and innovation is very tricky business and until now, most of evidence to support these claims has been anecdotal. According to an article in today’s New York Times, a report by the Information Technology and Innovation Foundation suggests that the US ranked sixth among 40 countries and regions based on 16 indicators that measure innovation and competitiveness including venture capital investment, numbers of per capita researchers, research spending and educational achievement. 

While the results of Foundation study may be troubling (if you are a US citizen), another recent study conducted by the World Economic Forum found that America ranked first in innovation and global competition. However the forum’s report was based entirely on opinion survey data.  Like the forum report, a study conducted by the Rand Corporation last year, also found that “the US was not in any imminent danger of losing its competitive advantage in science and technology.” The use of the word “imminent” is perhaps the most telling aspect of the Rand Corporation’s conclusion about American competitiveness.

The US lost ground to much smaller countries like Sweden, Finland, Taiwan, Singapore and also to one of it's main competitors, China.  Unlike the US, all of these countries are pursuing government-sponsored initiatives designed to promote innovation and global competitiveness. Some of the elements of these initiatives include education, workforce development training, intellectual property protection and immigration. Surprisingly, results from the foundation report (adjusted for population and size of each economy) showed that the US ranked sixth in venture capital investment (Sweden was first); fifth in corporate research and development spending (Japan was number one) and fourth in the number of science and technology researchers (again Sweden was first). Over all, Singapore ranked first in innovation and competitiveness. As some of you may know, Singapore--for the past 10 years--has heavily invested in the life sciences and has managed to induce some of world’s leading bioscientists to immigrate.

One of the main recommendations of the report suggests that the federal government ought to follow the lead of the individual states, many of which developed state government-sponsored programs designed to attract investment, talent and improve the work force skills of  local would be employees. Further, the report specifically recommends that the federal government offers tax breaks and incentives to induce American companies to innovate at home rather than outsource R&D activities abroad. Some of these incentives could include tax research tax credits  and increased federal funding or corporate tax breaks for workforce development programs.

Finally, one of the most shocking statistics that I heard in President Obama’s speech to Congress last evening was that 50% of American students drop out of high school and over 50% of college students never complete their education. This begs the question: How can America expect to remain competitive when a majority of its population is less educated than the rest of the developed world? 

A past commitment to education is what propelled the US to become a world leader in innovation and competitiveness.  To regain its past status as an innovator, the US must overhaul and vastly improve is primary, secondary and post secondary education system. This is something that cannot wait—the future of American depends on it!

Until next time...

Good Luck and Good Job Hunting ( give teaching a shot)

• Email This
• Print
• Comments (1)
• Trackbacks
• Share Link

I have been accumulating anecdotal information about companies,organizations and institutions that use social media tools like Facebook, Twitter YouTube etc.  I decided to attempt to conduct an informal survey  to determine whether or not the life sciences sector is adopting and embracing social media to meet its objectives (whatever they may be). 

To that end, I constructed a Google Docs spread sheet to collect information for the survey.  Please take a look at the survey and fill in the requested information. I will publish the results of the survey if enough people response to this request.

I look forward to hearing from as many of you as possible. Don't be shy, everything is anonymous!

Until next time...

Good Luck and Good Tweeting!!!!!

• Email This
• Print
• Comments
• Trackbacks
• Share Link

• Email This
• Print
• Comments
• Trackbacks
• Share Link

We recently added a feature to BioCrowd called BioCrunch. Our goal for BioCrunch is to provide Bcrowd members with relevant, interesting and “fresh” content. Vincent and I are big fans of podcasts and PowerPoint presentations! That said, please contact me  if you are interested in contributing content for BioCrowd’s BioCrunch feature.

Until next time…

Good Luck and Good Surfing!!!!

• Email This
• Print
• Comments
• Trackbacks
• Share Link

In the February issue of Genetic Engineering and Biotechnology News, J. Leslie Glick a former CEO of Genex and veteran of the biotechnology industry put forward a novel solution to financial crisis that is currently gripping the life sciences industry and the rest of the US economy. Dr. Glick proposed that the US government ought to consider injecting taxpayer monies into venture capital firms (VC) which, he believes, would foster creation of new companies, create more jobs, stimulate the ailing economy and also provide the government with an outstanding return on its investment.

According to Dr. Glick, “historical results reported by the National Venture Capital Association for the 20 year period ending December 31, 2007, show an annualized return of 16.7% to investors in some 1,860 U.S. venture capital and private equity partnerships. If the U.S. government had made annual investments of $10 billion in VC firms throughout the U.S. during that 20year period, the $200 billion total investment would have yielded a total return of almost $1.5 trillion.” Further, he asserts that according to the  International Trade Administration of the Department of Commerce, from 1970 to 2000, U.S. VC firms invested over $270 billion in more than 16,000 companies. In 2000, the surviving VC-backed companies employed 7.6 million people, representing 5.9% of all U.S. jobs, and generated sales of $1.3 trillion, accounting for 13.1% of the U.S. GDP.

This financial upside sound enticing but who is going to keep track of the money and keep an eye on how and what the VCs are investing in? Dr. Glick proposes creation of a non-partisan funding mechanism, possibly overseen by an independent panel of business people that would disburse $10 to $25 billion annually of taxpayer’s dollars to vetted and certified VC firms. Because of its investment, the US government would become a limited partner in these firms and could direct them to invest in technologies that would help to reduce health care costs, develop energy alternatives or improve food production capacity. While this proposal is unprecedented and controversial, we are living in extremely uncertain financial times that may necessitate innovative and out-of-the-box solutions to restore normalcy to the US economy. That said, all proposals—no mater how unconventional or outrageous—ought to be carefully evaluated and vetted to determine whether or not they have merit to help overcome our deepening recession.

Kudos to Dr. Glick!

Until next time,

Good Luck and Good Investing!!!!!!

• Email This
• Print
• Comments (1)
• Trackbacks
• Share Link

Earlier this month, Vincent Racaniello and I launched a new social network called BioCrowd. Vincent and I created BioCrowd because we believe that social media has a critical role to play in the evolution of the life sciences and existing 'science social networks' were difficult to navigate or too broad to adequately meet the needs of the bioscience community.

Our objectives are  to promote scientific and business interactions between BioCrowd members and offer advice to members who may be seeking to advance their careers or find jobs. To that end, we decided to create a monthly podcast that will keep network members apprised of all of the comings and goings at BioCrowd.

Please send us your feedback on our very first podcast.  Also, feel free to suggest topics that you would like discussed on future podcasts! 

Until next time...

Good Luck and Good Listening!!!!!!!!! 

• Email This
• Print
• Comments
• Trackbacks
• Share Link

Vincent Racaniello, a pioneer in RNA virology and world class researcher on the pathogenesis of polio, believes that social media can be used to enhance scientific research and improve science education. Vincent recently blogged about this on his virology blog and graciously allowed me to repost it to BioJobBlog. It is an interesting perspective from an innovative and creative scientist.

Science and the Social Web

In a previous post about why I blog and podcast, I discussed how these activities allow me to think more about virology and to teach far more people than I ever could in a laboratory or classroom. Is there even more value in the web for scientists?

There are three different web activities, besides blogging and podcasting that enhance science in new ways. The first is the ability to post comments on blogs and podcasts. In so doing, people can interact in ways that were not previously possible. Scientists who have never met, or students hoping to learn, all can connect and create an instructive and creative dialog. Don’t understand something in a post? Just ask. Have something different to contribute? Post it. Science can only benefit from interactions not limited by geography or time.

The second powerful web tool for science is the social networks. We know how MySpace and Facebook made it easy to meet and interact with new people. These networks also allow scientists to connect and talk about their profession. There are various groups on Facebook that enable focused, productive discussions among scientists. Even more useful are the social networks that have been developed specifically for scientists - well over 20 according to this  blog post. These networks exist to foster interactions - meeting other scientists, looking for jobs, troubleshooting experiments, finding answers to thorny questions. The value of scientific social networks is that they enable dialogue far beyond what you could achieve on your floor, in your building, by telephone or email. The result is scientific interactions at unprecedented levels.

The third web tool for scientists is Twitter. This microblogging platform restricts users to posts of 140 characters or less - the end result is concentrated information. For scientists, Twitter can be either a distraction or a gold mine. If you choose to follow individuals who are interested in science, you will, in the course of a day, find tweets with links to interesting science - news or journal articles; comments on science; questions about science or science methods - in brief, the kind of exchange originally facilitated by email but far more immediate and pithy. Follow the right people on Twitter, and receive useful information. I keep an eye on Twitter to find tips on how scientists use the web, the latest science news, and comments on science in general. In turn, when I learn of an interesting science news event or article, I tweet it. Mr. Tweet’s discussion of  the evolution of a twitter user crystallizes this concept.

There is also great value for scientists at FriendFeed. No, it’s not a fourth category - it’s an aggregator of the three activities described above, one-stop for all your blogging, podcasting, social networking, and twittering.

These three aspects of the social web are revolutionizing science. By using them, I am learning more about my field than I ever have before. Those who choose not to take advantage of the social web will miss the opportunity to become more creative and productive scientists.

• Email This
• Print
• Comments (1)
• Trackbacks
• Share Link

Did you know that the top ten pharmaceutical companies in the world spent close to $50 billion dollars last year on R&D? That sum could be used to purchase the entire US biotechnology industry except for the five largest companies—Genentech, Amgen, Gilead Genzyme and Celgene. Further, pharma’s R&D budget is about 4 times the R&D budget of all of the US biotechnology companies combined. According to a blurb in breakingviews.com, Pfizer alone spent $8 billion last year which was greater than the sum spent by biotech’s top five companies. What this tells us is that pharmaceutical companies are grossly unproductive when it comes to drug discovery and development. This would explain why nearly three-quarters of all new medicines approved for sale in the US last year originated at biotechnology companies.

It is becoming increasingly apparent that biotechnology companies are much more efficient at R&D than pharmaceutical companies. More importantly this suggests that something must change so that pharma can continue receive adequate ROI on internal discovery programs. Perhaps big pharma ought to spend a greater portion of its R&D budget on biotech mergers and acquisitions rather than continuing to invest in inefficient and failing internal R&D programs. While biotechnologynology companies are exceptional in drug discovery, they are severely lacking when it comes to clinical development of new drugs. This is largely due the high costs of conducting human clinical trials (which are required for regulatory approval of all new medicines). Most biotechnology companies are strapped for cash and don’t have sufficient funds to conduct clinical trials on their own.

Not surprisingly, given the recent financial downturn, there has been a recent spate of deals in which pharma has been willing to pay large sums of money for clinical development rights to promising new biotechnology drugs. Moreover, a majority of the almost 160,000 employees layed off by pharma companies in the past few years have been R&D scientists. This suggests that pharma is beginning to realize that its money may be better spent doing deals or buying biotech companies rather than continuing to invest large sums of money into it’s own unproductive R&D programs. Unfortunately, this paradigm shift doesn’t bode well for doctoral students and post-doctoral fellows who are training in the life sciences. This is because many entry-level biotech positions, traditionally filled by newly-minted PhDs and postdoctoral fellows will likely be filled by experienced, pharmaceutical employees who lost their jobs in the recent rounds of layoffs. As much as I hate to say this, if I were a life sciences graduate student or postdoctoral fellow considering an R&D career in industry, I would begin to explore alternative career options.

Until next time….

Good Luck and Good Job Hunting!!!!!!!

• Email This
• Print
• Comments
• Trackbacks
• Share Link

Like it or not, the best way to land a new job whether or not there is a recession is to network. While career counselors and recruiters trumpet the virtues of networking to job seekers, many people really don't understand what it is or how to do it correctly. I found an outstanding article that demystifies networking and offers tips on how to excel at it. 

For many scientists, online networking is ideal because they frequently lack the requisite skills to effectively network in real life situations. Until recently, face-to-face networking at conferences or "professional social events" was the only way to effectively network. However, the advent of web-based social networks allows job seekers to eschew the awkwardness and time requirements for  one-on-one networking in favor of a more convenient and less-threatening online experience. BioCrowd, a new online social network for scientists and other bioprofessionals, was created to help scientists advance their careers and find new jobs. While BioCrowd and similar online networking sites can help scientists make connections, it is still the face-to-face networking experience that will ultimately  help them land new jobs!

Because networking is not taught or emphasized in graduate school, it is not surprising that many graduate students and postdoctoral fellows are notoriously poor “networkers.” That said, for those of you who recognize the importance of networking and want hone your networking skills, Contacts Count a Maryland-based network training company may be worth a visit. I have no doubt that there other organizations and companies out there that specialize in network training. If you find any, let me know and I will gladly post them!

Until next time…

Good Luck and Good Job Hunting

• Email This
• Print
• Comments (2)
• Trackbacks
• Share Link

For the past five years, I have been giving career development seminars that offer graduate students and postdoctoral fellows alternate careers choices (instead of research) for life scientists. The intent of these seminars is to get students who may not be enamored with a possible life long career at the bench (I know that there a lot of you out there) to think about what they really want to do after they complete their graduate or postdoctoral training.

I recently met Jane Chin (on Twitter) who, like me, has had an unorthodox career trajectory for a life scientist. After exchanging several tweets, I learned that we both are microbiologists, Cornell University graduates, entrepreneurs and social media enthusiasts. But, the main reason I am telling you about Jane is that she crafted a fascinating PowerPoint presentation entitled “3 Lessons About Career Life From a Career Nomad” that provides insights into the decisions and choices that she made to shape her current career path. I highly recommend that you take a peek at the presentation—it may help to reduce some future career stress and angst!

Until next time…

Good Luck and Good Job Hunting!!!!!!

• Email This
• Print
• Comments
• Trackbacks
• Share Link

The other day I was chatting with Tony Stubblebine of CrowdVine (the social networking company building BioCrowd for us) and I was lamenting the possible burst of the social networking bubble before BioCrowd is launched. Tony reassured me and said that “Everyone thinks that after the dot-com bubble burst that almost all Internet-based businesses failed. However, when you look more closely, you will find that this simply isn’t true—there were many survivors who were able to build robust business as the Internet matured.”  While I felt a bit better after hearing that (Tony generally knows what he is talking about) I wasn’t totally convinced that he was right. After all, I am one of his customers who are building a new social network. That said, the very next day after my chat with Tony, I found an unusually. insightful article in the New York Times entitled “Lessons of Survival, From the Dot-Com Attic.”

The authors of the article suggest that based on their analysis of existing data that 48% of dot-com companies founded in 1996 were still in business in 2004 (more than four years after the Nasdaq’s peak in March 2000 and the so called dot-com bubble burst). According to the authors, “most people are stunned by this figure: they tend to guess that about 90% of the companies failed.” Further they suggest that “the dot-com survival rate is as good as or better than that for technologies like automobiles, tires and televisions during their formative years.”

How did the dot-com survivors do it? Instead of trying to a make a big splash in high profile market sectors, they identified niche markets that didn’t offer ROIs of hundreds of millions of dollars returns but represented viable Internet-based, business opportunities that could flourish if nurtured correctly. This largely assuaged most of my concerns about a possible impending social network bubble bust and proved to me that Tony knows his stuff! So, whether or not the social network bubble is going to burst, BioCrowd will be launched and we hope that like any new member of a species that it will be strong and fit enough to survive! 

Until next time.

Good Luck and Good Job Hunting!!!!!!!

• Email This
• Print
• Comments (1)
• Trackbacks
• Share Link

I never truly understood the power and reach of Twitter until I caved in and started using it about a month ago. Over the past couple of weeks, I realized that Twitter is an ideal tool for networking and job hunting. Apparently, I am not alone. Miriam Salpeter from Keppie Careers has graciously agreed to shares some tips on using Twitter to help you search for a Job. Follow Miriam on Twitter @Keppie_careers. 

Tweeting Your Way to a Job

Would you believe that you can tweet yourself to a job opportunity 140 characters at a time? It’s been done! Statistics show that job search networking is much more effective when you make “loose” connections - touching base with people beyond your immediate circle whose networks and contacts are much different from your own. With over 3 million users, Twitter offers an unparalleled opportunity to create an extended network.

Not convinced that Twitter is actually a high-powered job search tool? Read on to learn how Twitter can uniquely position you for job-hunting success!

What Can Twitter Do For You?

1. Afford access to other professionals in your field. When you follow industry leaders, you’ll know who spends time with them, what conferences they attend (and what they think of the speakers!), what they’re reading and what is on their minds. This is great information to leverage for your search.
2. Provide exposure and credibility as well as personal and professional relationships when you connect to others in your industry.
3. Offer you a venue to demonstrate your expertise and share information in quick, pithy bursts of wisdom. This is perfect if you don’t have the time or energy to create a blog.

Unique Aspects of Twitter

1. It is casual and immediate and a great place to “meet” informally.
2. You’ll find an array of people on Twitter, including CEOs, top-level executives, hiring managers, recruiters and everyone in-between! It’s one-stop shopping for your networking needs. You’ll be surprised to find that stars in your field (mentors) may follow you if you reach out to them!
3. Unlike Facebook, where it is kind of creepy if you start trying to “friend” people who are connected to your contacts, it is acceptable (and expected) to follow people on Twitter because another friend or colleague does.
4. It forces you to be brief. Coming up with your “Twit-Pitch” - what you have to offer in 140 characters or less - will help you clarify your value proposition. Remember: less is more!

 It Really Does Work!

1. Kyle Flaherty used Twitter to find a job that moved him and his family to Austin, TX from Boston. He tweeted to approximately 650 contacts that he had left his job. He included a link to a blog post outlining his interest in connecting. He explains, “Within hours I had several emails, IMs, phone calls and tweets about the topic and it actually ended up that I took a new job.” Follow this link for an interview with Kyle’s new boss, Pam O’Neil, who explains how she and Kyle used Twitter to fill the position.
2. Heidi Miller, the “Podcasting Princess,” found a freelance project using Twitter by tweeting updates about her job hunt. Many of her colleagues questioned the wisdom of being so open about her search; they worried she look desperate or foolish. However, the ends justified the means.

As more and more get involved (dare I say addicted?) to Twitter, opportunities to leverage this tool for job search networking will grow exponentially. Don’t be the one left behind! Get on board and start connecting for success!

• Email This
• Print
• Comments (1)
• Trackbacks
• Share Link

I just returned from the Annual Biomedical Research Conference for Minority Students (ABRCMS) that was held in Orlando from November 5-8, 2008. The annual meeting, which is configured like most life sciences conferences with plenary oral sessions and poster presentations, is primarily intended to expose minority students to possible career opportunities in the life and biomedical sciences. I was at the meeting working for FASEB Careers as a career development and resume critiquing consultant.  

I have to say that this year's  ABRCMS was one of the most exciting and motivational meetings that I have attended in my career as a scientist and educator. Part of  the excitement and upbeat feeling at the meeting may have been a direct  result of last Tuesday's historic election of Barack Obama (who wasn't excited?).  Nevertheless, I met countless numbers of bright,  highly motivated and talented minority students who want to pursue careers in science, medicine and sometimes both! I was pleasantly surprised to learn that many of the undergraduate students who attend this meeting are actively engaged in basic research in laboratories at their institutions. Further, unlike many of their non-minority counterparts, most of the students who I chatted with were well informed about their intended careers and had divined well thought out strategies to help them realize their career goals and aspirations.

Kudos to the conference organizers and their sponsors! I look forward to attending next year’s conference in Phoenix, AZ.

Until next time…

Good Luck and Good Job Hunting!!!!!

• Email This
• Print
• Comments (2)
• Trackbacks
• Share Link

Pharmaceutical Technology Europe published a list last month called the Pharma Exec 50 for 2008. To qualify for the list, companies had to have more than $510 billion in sales.  Unlike other lists of this ilk, it is easy to read, visually appealing and mentions each company’s top selling drugs and their annual R &D spending.  It is definitely worth a read by people who need or like to stay abreast of the life sciences industry. And for a change, the list was compiled by a European rather than an American publication. Not that there is anything wrong with that!

Good Luck and Good Job Hunting!!!!

• Email This
• Print
• Comments
• Trackbacks
• Share Link

I became a medical/science writer after a rather circuitous, unconventional and sometimes, checkered career. Along the way, I learned a few things that I thought would be important to share with other PhDs who are seeking to change careers, t broaden their horizons and or simply to bring home a paycheck! I am sure that I missed a few things but here are my top 10 reasons to consider a career in medical/science writing:

10. Academic and industrial jobs are scare 
9.   No postdoctoral training is required
8.   Previous industrial experience is not a prerequisite for employment
7.   No laboratory work must be done to publish
6.   Starting salaries range from $40-$50 per hour or $75-90K annually 
5    There is a growing need for therapeutic area content experts
4.   Assignments change regularly and there is an enormous of amount of flexibility in when    and how you work 
3    Although a writer doesn’t perform any laboratory work, there is an opportunity to utilize the scientific skill sets (data analysis, thinking and problem solving) that you learned during your graduate training
2.   Even when times get tough, writers are always in high demand because publishing is the life blood of science
1.  You enjoy writing, thinking creatively and working with an eclectic bunch of people who are not scientists!

Until next time..... 

Good Luck and Good Writing!!!!!!!!

• Email This
• Print
• Comments (1)
• Trackbacks
• Share Link

The social development of the web 2.0 has largely bypassed science. Hugely popular websites such as Facebook, MySpace, Twitter, Digg, Delicious and the like have millions of members and generate huge amounts of traffic. But those who use these sites come from all walks of life. None are devoted solely to science.

With this in mind, it would seem that social networking sites that cater to scientists would have special value and appeal. A few have been launched —but there is certainly room for improvement.

This fall, Vincent Racaniello at the College of Physicians and Surgeons at Columbia University and I will launch BioCrowd.com, a new social network designed by scientists (Vincent and me) for bioscientists (and others in the life sciences) who wish to connect with others to advance, promote or shape their careers.

Please visit the home page to sign up to be notified when we launch. BioCrowd will combine the interactivity of sites like Facebook and the networking capabilities of LinkedIn to help to advance your career in the biosciences.

Be part of  "The BioCrowd" !!!!!!!!

• Email This
• Print
• Comments (1)
• Trackbacks
• Share Link

For the past 60 years, American science was second to none. However, the US is perilously close to losing that distinction. Put simply, American science, like its economy, is in free fall.

Federal funding, primarily through the National Institutes of Health (NIH), is the lifeblood of American life sciences research. Between 1998 and 2003, the federal government doubled NIH’s budget every year—almost 25% of all grant applications were funded and life was good! However, since 2003, budget increases have vanished and the NIH remains trapped in a five year run of flat funding. Research funding rates have fallen to 10% or less and many academic scientists are voluntarily leaving or being forced out of their jobs.

This is not the first time that funding levels have plummeted. From 1989 to about 1994 (when I was a tenure track Assistant Professor), funding rates fell from about 20% to less than 10%. However, back then, there was little global research competition and American was able to recover to retain its scientific dominance. However, the world is a very different place now and the supremacy of American science, particularly in the life sciences, is clearly at risk.

According to an article in the Trenton Times, (my local paper), science and engineering have accounted for close to half of the growth in the American economy since World War II. Analysts suggest that without adequate research funding and ready access to research grants fewer scientists will enter the profession. “Already Asian countries are graduating 10 times the number of scientists and engineers as the United States. If the current trends continue in about a decade 90% of the world’s scientists and engineers will be in Asia” According to Elias Zerhouni, current director of NIH “In 10 to 15 years we’ll have scientists older than 65 than those younger than 35. This is not a sustainable trend in biomedical research.” Unless federal funding for research is increased this ominous trend will continue. That said, it may be too little too late. As you all know, finding science jobs in the US these days is becoming increasingly difficult even for qualified applicants. With this in mind, one of the most well attended talks that I give at career development symposia is entitled “The Road Less Traveled: Alternate Career Paths for Life Scientists”. As much as I hate to admit it, traditional career pathways for most life scientists may be things of the past.

Clearly, something must be done to fix the problem in order to maintain the quality of American science. The easy fix, which has been used ad nauseam for the pasts two decades, is to increase short term federal research spending. However, history indicates that this approach fosters the boom and bust cycles that have continually plagued American academic science. Although the boom and bust approach is quintessentially American, I don’t think that it will enable American science to sustain its scientific dominance in today’s increasingly competitive world.

The number of young people interested in or entering science continues to plummet in the US. Ironically, the quality and access to American science education has never been better! So, why the disconnect? It’s simple—science jobs are scare, the pay is not great and life as an academician has become almost unsustainable. In my opinion, something has to change very soon or America will almost certainly lose its status as the preeminent purveyor of science in the world.

Until next time,

Good Luck and Good Job Hunting!!!!

• Email This
• Print
• Comments
• Trackbacks
• Share Link

According to a survey of 1,800 American professors in the life sciences conducted by economists at the University of Wisconsin-Madison, 90% of life sicentiest hold only one or no patents.  This means that  remaining 10% hold more than one (and are probably weathier than the other guys). 

The results of the study led its authors to surmise that despite the recent explosion in patenting in the life sciences, a majority of academics still do research the "old-fashioned way"--by winning federal research grants, publishing in scientific journals and training PhD and postdoctoral students.  Yeah right--I bet many of the old-fashioned folks wish they had patents and were able to start biotechnology companies!!!!

Until next time....

Good Luck and Good Patenting!!!!!!!

• Email This
• Print
• Comments
• Trackbacks
• Share Link

This is the first installment of Kevin Ahern’s Best of the Web at BioJobBlog. This month’s selection contains several technical sites that many practicing bioscientists will find useful. These include: Real Time PCR Primer Sets and RTPrimerDB. The selection that I found most interesting was Blogging the Biotechnology Revolution—although Kevin didn’t like the navigation features of this blog.

If you know of any websites, blogs, etc that you think are useful or interesting, please let me know.

Until next time…

Good Luck and Good Web Hunting!!!!!!!

• Email This
• Print
• Comments
• Trackbacks
• Share Link

I came across this excellent article written by Carol Martin a professional career coach.  The tips that she provides are useful and have stood the test of time!  So read and learn!!!!

Not getting a follow-up call when promised is a very common occurrence. Candidates are sometimes sure that they aced the interview and are perfect for the position, in fact they are anticipating a call and an offer. But instead they get "nothing." No offer; no call. They never hear from the company. This is not only frustrating, but reflects poorly on the company. In fact it is rude. What can you do about this situation? Here are some tips on how to handle the follow up that may save you from some anxiety.

1. Try to find out about the decision-process before you leave the interview. Ask when you could expect to hear back. Take that date and then add a few days before you start to worry.

2. Always send a follow up addressing any concerns you may have picked up or any thoughts you had about the position since the interview. Think of this as one more chance to put yourself in front of them.

3. After you have waited for a reasonable period beyond the date they stated, call and inquire as to the status of the position and whether you are still in the running.

4. As a general rule, don't call on Mondays - bad day to market anything. 5. If you leave a message inquiring about the status of the job, and no one calls you back after a couple of attempts - move on and forget about it. Don't call back more than a couple of times. There is a fine line between being persistent and being a pest. 6. If you are told you are no longer under consideration, try asking for feedback (most of the time they won't give you any, but still worth a try). Ask if there is any additional information that you can supply that will convince them that you are the right person for the job.

7. Don't rely on one job interview. No matter what was said in the interview – continue your search. There have been too many bad examples of those who thought they were a shoe-in - only to get a reject letter.

8. Don't take it personally! There are about a thousand reasons that could have affected your chances.

9. Accept the fact that not all companies are right for you. Just like blind dates - they are checking you out and you are checking them out. Sometimes it's chemistry – and sometimes it wasn't right for you – for whatever reason.

10.Try not to get discouraged by the rejects. It's a numbers game and your turn will come if you hang in there.

Copyright (c) 2007 Carole Martin, The Interview Coach

Until Next Time….

Good Luck and Good Job Hunting!!!!!!!!!

• Email This
• Print
• Comments (3)
• Trackbacks
• Share Link

I came across an interesting article in Forbes Magazine that identified the top 10 places in America that are not being dramatically impacted by our slowing (are we in a recession yet) economy. According to the article they are:

1. Oklahoma City, OK

2. San Antonio TX

3. Austin, TX

4. Houston, TX

5. Charlotte, NC

6. Dallas, TX

7. San Jose, CA

8. Raleigh, NC

9. Salt Lake City, UT

10. Seattle, WA

For those of you, who are interested in seeing photos and garnering some interesting stats about these cities, click here.

A quick perusal of the list shows, that most of these cities are either south of the Mason Dixon Line or West of the Continental Divide. Unfortunately, none of the cities are hotbeds of biotechnology or life sciences research (with the possible exception of Seattle). It seems that if you live in Texas, you may be living large. But, then again, isn’t everything BIGGER in Texas?

Until next time….

Good Luck and Good Job Hunting (try Austin, it rocks)!!!!!!!!!

• Email This
• Print
• Comments (1)
• Trackbacks
• Share Link